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Recent studies have shown that RNA sequencing (RNA-seq) can be used to measure
mRNA of sufficient quality extracted from Formalin-Fixed Paraffin-Embedded (FFPE) tis-
sues to provide whole-genome transcriptome analysis. However, little attention has been
given to the normalization of FFPE RNA-seq data, a key step that adjusts for unwanted
biological and technical effects that can bias the signal of interest. Existing methods,
developed based on fresh frozen or similar-type samples, may cause suboptimal perfor-
mance. In Chapter 1, we propose a new normalization method, labeled MIXnorm, for
FFPE RNA-seq data. MIXnorm relies on a two-component mixture model, which models
non-expressed genes by zero-inflated Poisson distributions and models expressed genes
by truncated normal distributions. To obtain maximum likelihood estimates, we develop
a nested EM algorithm, in which closed-form updates are available in each iteration. By
eliminating the need for numerical optimization in the M-step, the algorithm is easy to
implement and computationally efficient. We evaluate MIXnorm through simulations and
cancer studies. MIXnorm makes a significant improvement over commonly used methods
for RNA-seq expression data.
MIXnorm has been shown to outperform the normalization methods developed based
on FF RNA-seq data, but at the cost of a complex mixture model and a high computa-
tional burden. It is therefore important to adapt MIXnorm for simplicity and computational
efficiency while maintaining superior performance. Furthermore, it is critical to develop
v
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an integrated tool that performs commonly used normalization methods for both FF and
FFPE RNA-seq data. In Chapter 2, we develop a new normalization method for FFPE
RNA-seq data, named SMIXnorm, based on a simplified two-component mixture model
compared to MIXnorm to facilitate computation. The maximum likelihood estimates of the
model parameters are obtained by a nested Expectation-Maximization algorithm with a
less complicated latent variable structure, and closed-form updates are available within
each iteration. Real data applications and simulation studies show that SMIXnorm greatly
reduces computing time compared to MIXnorm, without sacrificing the performance. More
importantly, we developed a web-based tool, RNA-seq Normalization (RSeqNorm avail-
able at http://lce.biohpc.swmed.edu/rseqnorm), that offers a simple workflow to compute
normalized RNA-seq data for both FFPE and FF samples. It includes SMIXnorm and
MIXnorm for FFPE RNA-seq data, together with five commonly used normalization meth-
ods for FF RNA-seq data. Users can easily upload a raw RNA-seq count matrix and
select one of the seven normalization methods to produce a downloadable normalized
expression matrix for any downstream analysis.
Recently, spatial molecular profiling technologies have enabled a comprehensive cat-
alog of molecular profiling data together with tissue imaging data with spatial locations
and organizations. In the context of spatial profiling, the research interest lies in inves-
tigating the association between gene expression levels and their spatial locations, i.e.,
identifying spatially expressed (SE) genes. However, gene expression data from spatial
molecular profiling are subject to severe zero-inflation issues. In Chapter 3, we propose a
Bayesian Spatial HEAPing model (SHEAP), which aims to accurately recover major spa-
tial patterns underlying the gene expression levels that are partially observed and subject
to heaping at zero. An efficient Markov chain Monte Carlo (MCMC) algorithm is developed
for Bayesian inference. We evaluate the proposed method through simulation studies and
two real data applications. SHEAP shows significant improvement in detecting SE genes
compared to existing methods.
vi
TABLE OF CONTENTS
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . x
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiv
CHAPTER
1. MIXnorm: Normalizing RNA-seq Data from Formalin-Fixed Paraffin-Embedded
Samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2. An Exploratory Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.3. The MIXnorm Method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.3.1. The statistical model for FFPE data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.3.2. Model fitting via an EM algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.3.3. Review of nested EM algorithms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.3.4. Model fitting via a nested EM algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.3.5. Normalizing gene expression and identifying expressed genes . . . 13
1.4. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.4.1. Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.4.2. Data application . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.5. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2. SMIXnorm: Fast and Accurate RNA-seq Data Normalization for Formalin-
Fixed Paraffin-Embedded Samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.2. Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.1. The SMIXnorm method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.2. RSeqNorm web portal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
vii
2.3.1. Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.3.2. Data application . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.4. Discussions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3. SHEAP: Detecting Spatially Expressed Genes via a Bayesian Spatial Heap-
ing Model for Zero-Inflated Spatial Transcriptomics Data . . . . . . . . . . . . . . . . . 44
3.1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.2. Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.2.1. A spatial heaping model for count data . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.2.2. Prior specification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.2.3. Posterior computation and inference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
3.3.1. Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
3.3.2. Data application . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.4. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
APPENDIX
A. APPENDIX of CHAPTER 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
A.1. Approximating a discrete distribution by a continuous distribution . . . . . . . . 65
A.2. Technical Details of the Nested EM Algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
A.3. Performance Evaluation via Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
A.3.1. Settings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
A.3.2. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
A.4. Additional Results for Data Applications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
B. APPENDIX of CHAPTER 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
B.1. Nested EM algorithm for SMIXnorm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
B.2. Web Appendix B: Additional simulation results . . . . . . . . . . . . . . . . . . . . . . . . . . 87
viii
C. APPENDIX of CHAPTER 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
C.1. MCMC algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
BIBLIOGRAPHY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
ix
LIST OF FIGURES
Figure Page
1.1 An exploratory analysis of RNA-seq data in Lesluyes et al. [29]. Panel
(a)/(b) shows the histogram of zero-count proportion among 41 FFPE/FF
samples (represented by the horizontal axis) based on a total of
20,242 genes. Panel (c)/(d) shows empirical densities of log read
counts for the 41 FFPE/FF samples. Each curve in (c)/(d) represents
the density for one sample across all the 20, 242 genes. . . . . . . . . . . . . . . . . . . 5
1.2 Soft tissue sarcomas data example: the normalized FFPE vs. FF ex-
pressions in the log scale from all 41 samples for all 67 genes in
the CINSARC gene signature. The left panel shows scatterplots for
MIXnorm, TMM and DESeq, and the right panel shows scatterplots
for RPM, PS and the original data (without any normalization). Pear-
son correlation coefficients are reported for each method in the legend. . . 17
1.3 ccRCC data example: normalized expressions levels of CA9 (Panel A),
SLC6A3 (Panel B), UMOD (Panel C) and SLC12A1 (Panel D) from
FFPE samples. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.1 Summary of RSeqNorm web-portal process. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.2 RSeqNorm upload file requirements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.3 Diagnostic plot returned by RSeqNorm using SMIXnorm. . . . . . . . . . . . . . . . . . . . 36
2.4 Simulation study. Average computing time of SMIXnorm and MIXnorm
vs. sample size . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.5 Gene-wise correlations between normalized FFPE and FF expression
for soft tissue sarcomas data on all 20, 242 protein coding genes. The
UQ method failed to normalize the data due to excess zero counts. . . . . . . 40
2.6 Gene-wise correlations between normalized FFPE and RNAlater for ccRCC
data on 18, 458 protein coding genes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.1 Spatially resolved expression profiles. (A) example of spatially expressed
(SE) gene. (B) example of non-spatially expressed gene. . . . . . . . . . . . . . . . . 46
x
3.2 The hierarchical structure of the SHEAP model. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.3 ROC curves at the false discovery rates from 0 to 1 for Simulation I. (A) no
extra zeros. (B) low proportion of extra zeros. (C) median proportion
of extra zeros. (D) high proportion of extra zeros. . . . . . . . . . . . . . . . . . . . . . . . . 61
3.4 ROC curves at the false discovery rates from 0 to 1 for Simulation II. (A)
low spatial correlations. (B) high spatial correlations. . . . . . . . . . . . . . . . . . . . . 62
3.5 Mouse olfactory bulb data. Spatial expression patterns for 9 SE genes
identified by SHEAP. Expression levels are in the natural log scale.
These genes are known to have enriched expression in the mitral cell
layer (MCL) but low expression or even no expression in the adjacent
granular cell layer (GCL). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
3.6 Breast cancer data. Spatial expression patterns for 14 SE genes identi-
fied by SHEAP. Expression levels are in the natural log scale. These
14 extracellular matrix-associated genes are cancer relevant and char-
acterized as spatially expressed genes in the original study [53]. . . . . . . . . . 64
A.1 Simulation study I: the first three columns show box-plots for the 1st to 3rd
quartiles of 18, 458 gene-wise correlations between normalized and
true expression levels based on 100 replicates for the five settings
I1 - I5 that vary the proportion of expressed genes φ from 0.59 to
0.99 by 0.1; the last column shows the box-plot of the 18, 458 gene-
wise Pearson correlations calculated from the combined data, which
contains 100×32 samples in each setting. The MLE φ̂ estimated from
the ccRCC data is 0.79, which is the value of φ in Setting I-3 that can
be treated as the reference setting. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
A.2 Simulation study II: the first three columns show box-plots for the 1st to
3rd quartiles of 18, 458 gene-wise correlations between normalized
and true expression based on 100 replicates for the three settings
II1 – II3; the last column shows the box-plot of the 18, 458 gene-
wise Pearson correlations calculated from the combined data, which
contains 100 × 32 samples in each setting. In II-1, the sample spe-
cific location parameters µis were increased to 2 times of their MLEs
obtained from the ccRCC data. In II-2, the sample specific scale
parameters σis were increased to 2 times of their MLEs. In II-3,
δis, which control the sample specific background noise for non-
expressed genes, were increased to 2 times of their MLEs. . . . . . . . . . . . . . 76
xi
A.3 Simulation study III: the first three columns show box-plots for the 1st
to 3rd quartiles of 18, 458 gene-wise correlations between normal-
ized and true expression levels based on 100 replicates for the two
settings III1 – III2; the last column shows the box-plot of the 18, 458
gene-wise Pearson correlations calculated from the combined data,
which contains 100 × 32 samples in each setting. In setting III-1, the
variability of gene-wise noise σg was increased from 1.5 to 3 for ex-
pressed genes. In setting III-2, πjs, the probabilities of extra zero for
non-expressed genes, were set to a half of their MLEs. . . . . . . . . . . . . . . . . . 77
A.4 Simulation study IV: the first three columns show box-plots for the 1st
to 3rd quartiles of 18, 458 gene-wise correlations between normal-
ized and true expression based on 100 replicates for the three set-
tings IV1 - IV3; the last column shows the box-plot of the 18, 458
gene-wise Pearson correlations calculated from the combined data,
which contains 100 × 32 samples in each setting. In IV-1, a trun-
cated t-distribution was used to generate heavy-tailed data for ex-
pressed genes.In IV-2, a gamma distribution was used to generate
skewed data for expressed genes. In IV-3, the Poisson log-linear
model (model 3.1 from [31]), with modification to better mimic RNA-
seq data from FFPE samples, was used. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
A.5 Simulation study V: the first three columns show box-plots for the 1st to
3rd quartiles of 18,458 gene-wise correlations between normalized
and true expression based on 100 replicates for three settings V1
– V3; the last column shows the box-plot of the 18, 458 gene-wise
Pearson correlations calculated from the combined data, which con-
tains 100× 32 samples in each setting. Two strategies are compared
when DE genes exist across two experimental conditions: separate
normalization for each condition vs. pooled normalization for both
conditions. Each setting contains d% genes that are differentially ex-
pressed, where d was set to 5, 10 and 15, respectively. . . . . . . . . . . . . . . . . . 79
A.6 Simulation study VI: average computing time of MIXnorm vs. sample size
I (left panel) and number of genes J (right panel) . . . . . . . . . . . . . . . . . . . . . . . 79
A.7 An exploratory analysis of ccRCC RNA-seq data in Eikrem et al. (2016).
Panel (a) plots the empirical densities of log read counts for the 32
FFPE samples. Panel (b) plots the empirical densities of log read
counts for the paired RNAlater samples. Each curve represents the
density for one sample across all the 18, 458 protein coding genes. . . . . . . . 80
xii
A.8 Q-Q plots using the expressed genes identified by MIXnorm for four ran-
domly selected FFPE samples (NF10, NF31, TF32 and TF33) from
ccRCC RNA-seq data. The raw reads were transformed into the log
scale to calculate sample quantiles. Theoretical quantiles were cal-
culated from the TN distributions with sample-specific location and
scale parameters estimated by MIXnorm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
A.9 Results from bootstrap KL distributional tests for the 32 FFPE samples
from ccRCC RNA-seq data. Note that the y-axis represents− log10(p-value).
The horizontal line is located at y = − log10(0.05). All p-values are
greater than 0.05. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
B.1 Simulation study I. The 1st to 3rd quartiles of gene-wise Pearson corre-
lations for 20, 242 genes between the normalized and true expression
for 50 simulated data set under the setting of 41 samples. . . . . . . . . . . . . . . . . 88
xiii
LIST OF TABLES
Table Page
1.1 Data applications: the left and middle panels show gene-wise correla-
tions between normalized FFPE and FF expression for soft tissue
sarcomas data; the right panel shows gene-wise correlations be-
tween normalized FFPE and RNAlater expression for ccRCC data.
The Upper-Quartile method (UQ) failed to work for soft tissue sarco-
mas data due to excess zeros. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.2 ccRCC data example: summary of differential expression analysis based
on different normalization methods. The second column is the num-
ber of DE genes identified from the FFPE data; the third column is
the number of DE genes identified from the RNAlater data; the fourth
column is the number of common genes between the two sets of DE
genes; the last column is the number of common genes among the
two sets of top 20 DE genes from FFPE and RNAlater. . . . . . . . . . . . . . . . . . . 20
1.3 ccRCC data example: the 13 shared genes among the two sets of top 20
DE genes from FFPE and RNAlater, ordered by the absolute value
of the RNAlater log2 FC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.1 Correlations ρ between normalized FF and FFPE RAS pathway activa-
tion scores. p-values in the parenthesis are based on a two-sided
permutation test for the hypothesis H0 : ρ = 0. . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.2 Gene-wise correlations between normalized FFPE and FF expression for
soft tissue sarcomas data on the CINSARC gene signature. The UQ
method failed to normalize the data due to excess zero counts. . . . . . . . . . . 41
3.1 True positive (TP), false positive (FP) and area under the ROC curve
(AUC) results for Simulation I. Ten spatially expressed genes and ten
non-spatially expressed genes are generated in each setting. Zero,
low, median and high proportion of extra zeros correspond to approx-
imately 45%, 60% and 75% of zeros within each gene. TP (FP) is the
number of correctly (falsely) identified SE genes. . . . . . . . . . . . . . . . . . . . . . . . . 56
xiv
3.2 True positive (TP) and false positive (FP) results for Simulation II. Ten
spatially expressed genes and ten non-spatially expressed genes are
generated in each setting. l is set to 2.5- and 10-percentile of all
pair-wise Euclidean distances in the low and high spatial correlation
setting, respectively. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.3 Mouse olfactory bulb data. Analysis of the 10 marker genes in mouse
olfactory bulb data. LL and UL are the lower and upper limits of
the 95% credible interval of l. p0 is the proportion of l = 0 from its
posterior samples after burn-in. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.4 Breast cancer data. Analysis of the 14 extracellular matrix-associated
genes. LL and UL are the lower and upper limit of the 95% credible
interval of l. p0 is the proportion of l = 0 from its posterior samples
after burn-in. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
A.1 Simulation study I: the performance of MIXnorm in identifying expressed
genes, measured by the average proportion of genes detected as
expressed (column 3) and the average AUC (column 4) in each of
the five settings I1 – I5. Gene j is identified as expressed if w(t)j > 0.5
in the last iteration. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
A.2 Data applications: the left and middle panels show gene-wise correla-
tions between normalized FFPE and FF expression for soft tissue
sarcomas data; the right panel shows gene-wise correlations be-
tween normalized FFPE and RNAlater expression for ccRCC data.
Genes with mean reads across all samples less than or equal to 0.5
were excluded for normalization and the correlation calculation. The
filtered soft tissue sarcomas data contain 19, 408 genes and ccRCC
data contain 16, 044 genes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
xv
I dedicate this dissertation to my family.
CHAPTER 1
MIXnorm: Normalizing RNA-seq Data from Formalin-Fixed Paraffin-Embedded Samples
1.1. Introduction
Human tissue biospecimens are of two primary types, fresh-frozen (FF) and formalin-
fixed paraffin-embedded (FFPE) tissues. As fresh tissues deteriorate rapidly at room tem-
perature, FF samples must be frozen instantly after collection and then stored in freezers.
FF tissues are well suited for molecular analysis using gene expression measurements
as freezing preserves RNA well. However, they are expensive to store and transport,
and difficult to collect for large-scale studies. By contrast, FFPE samples can be stored
at room temperature and kept for a long time. Due to the ease of handling and inex-
pensive storage, numerous FFPE tissue samples have been deposited into tissue banks
and pathology laboratories around the world, and are readily available [42, 47, 48]. The
ubiquity of FFPE tissue specimens has made them an invaluable resource in biomedical
research, with great potential for predictive and prognostic biomarker discovery.
However, the quality of RNA extracted from FFPE tissues is a concern due to chemical
modifications and continued degradation over time. The process of using formalin to fix
and paraffin embedding to preserve tissues for an extended period of time is designed to
well preserve cellular proteins rather than preserving RNA. Consequently, assays using
microarray or quantitative polymerase chain reaction (qPCR) often have limited repro-
ducibility and sensitivity when measuring gene expression from such samples. In order
to exploit the vast collection of FFPE samples, substantial effort has been devoted to de-
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velopment and/or validation of advanced technologies that can reliably probe their gene
expression levels. For high-throughput profiling, RNA sequencing (RNA-seq), which uses
next-generation sequencing (NGS) to reveal the presence and quantity of RNA in a bio-
logical sample, is in common use. Recent studies have shown that for a wide variety of
human tumor tissues (e.g., bladder, colon, prostate and renal carcinoma), RNA-seq can
be used to measure mRNA of sufficient quality extracted from FFPE tissues to provide
biologically relevant transcriptome analysis [19, 20]. Meanwhile, recent FFPE RNA-Seq
solutions such as Illumina total RNA-Seq enable researchers to produce high-quality re-
sults from degraded samples. As a result, a drastically increasing number of studies have
used RNA-seq on FFPE specimens [33, 39].
A critical step when analyzing RNA-seq data is normalization. Normalization removes
systematic biases that affect measured gene expression levels (e.g., variability in exper-
imental conditions, sample collection and preparation, and machine parameters, etc.),
while preserving the variation in gene expression that occurs because of biologically rel-
evant changes in transcription. A number of normalization methods for RNA-seq data
have been developed [11]. A common approach is to normalize the measured expression
using (estimated) scaling factors. The most straightforward normalization method, Reads
Per Million (RPM) [38], estimates the scaling factor by dividing the total read count of a
sample by 1, 000, 000. The normalized data are the read counts divided by the scaling
factors. The Upper-Quartile (UQ) [4] method estimates the scaling factor by the upper
quartile of the read counts within each sample. DESeq [1] works under the assumption
that only a small subset of genes are differentially expressed (DE). First, for each gene,
the ratio of its read count over its geometric mean across all samples is calculated. Then
the scaling factor is estimated by the median ratio within each sample. Thus, it is also re-
ferred to as median normalization. Trimmed Mean of M-values (TMM) [49] is also based
on the assumption that most of the genes are not DE, where one sample is chosen as
the reference sample and the others as test samples. The log ratio of the read count be-
tween each test sample and the reference is computed for each gene. Then for each test
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sample, TMM estimates the scaling factor by the weighted mean of log ratios after exclu-
sion of the genes with extreme average expression or with largest log ratios. PoissonSeq
(PS) [31] models RNA-seq data by a Poisson log-linear model. The normalization is done
implicitly by including the scaling factor as a term in the model.
Though a number of normalization methods are available for RNA-seq data, none has
been specifically designed for FFPE samples, of which a prominent feature is sparsity
(i.e., excessive zero or small counts), caused by RNA degradation in such samples. The
quantile-based methods become problematic due to excess zeros that cause ranking ties.
For DEseq, the geometric mean is only well defined for genes with at least one read count
in every sample. The zero inflation is also a concern for methods that implicitly use scaling
factors such as PS since they all rely on Poisson or Negative Binomial distributions for
modeling count data.
To illustrate characteristics of RNA-seq data from FFPE samples, we begin by pre-
senting an exploratory analysis in Section 1.2 using a real data example. In Section 1.3,
we propose a novel normalization method, called MIXnorm, based on a two-component
mixture model for log read counts, to capture the sparsity as well as major mean and
variance structures underlying the data. Due to whole-genome sequencing, the number
of parameters involved is often very large. We develop an efficient nested expectation–
maximization (EM) algorithm to fit the proposed mixture model, where parameters are
updated via closed-form solutions iteratively. Section 1.4 briefly summarizes simulation
studies and expounds two real data applications to compare the performance of the pro-
posed MIXnorm to five commonly used RNA-seq normalization methods, including UQ,
DESeq, RPM, PS and TMM. Section 1.5 concludes the paper with a brief discussion.
Technical details, performance evaluation via simulation, and additional analysis results
are available in Appendix A.
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1.2. An Exploratory Analysis
As mentioned in the introduction, a striking feature of FFPE RNA-seq data is the spar-
sity, which can be observed in multiple data sets from independent studies. An example is
provided here using paired FF and FFPE samples from a published study, RNA sequenc-
ing validation of the Complexity INdex in SARComas prognostic signature [29]. Prognosis
of metastatic outcomes in soft tissue sarcomas is important because of its high recurring
rate (up to 50% of recurrence). Complexity INdex in SARComas (CINSARC), a gene
signature that consists of 67 genes, has been identified as a valuable prognostic factor
in sarcomas. This signature was originally identified on FF samples assayed by the mi-
croarray platform. The study goal of Lesluyes et al. [29] was to evaluate the prognostic
performance of CINSARC on both FF and FFPE samples. Thus, the resulting data set
contains gene expression levels for 20, 242 protein coding genes, measured by whole-
genome next generation sequencing on paired FF and FFPE samples from 41 patients.
We first transformed the raw read counts in this dataset into the natural logarithm
scale. In order to deal with zero counts, we define the log count L ≡ log(C + 1), where
C is the raw count. Figure 1.1(a) shows that among a total of 20,242 genes, there is a
significant portion of genes with more than 50% zero counts in FFPE samples while (b)
shows that over 65% genes, represented by the leftmost bar, do not have any zero count
in FF samples. Further, Figure 1.1(c) and (d) show that for each sample, regardless of
sample types, the commonly used Poisson or Negative Binomial distributions for count
data are far from being adequate to capture the bimodal density of gene expression (with
one spike at zero). Two other interesting observations from Figure 1.1(c) and (d) are:
(1) the locations of the distributions of 41 FFPE samples vary much more than those of
FF samples, indicating great heterogeneity in RNA degradation levels among the FFPE
tissues; and (2) densities from different FF samples show highly similar variability while
those from FFPE samples do not (the spread of the curves varies tremendously).
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Figure 1.1: An exploratory analysis of RNA-seq data in Lesluyes et al. [29]. Panel (a)/(b)
shows the histogram of zero-count proportion among 41 FFPE/FF samples (represented
by the horizontal axis) based on a total of 20,242 genes. Panel (c)/(d) shows empirical
densities of log read counts for the 41 FFPE/FF samples. Each curve in (c)/(d) represents
the density for one sample across all the 20, 242 genes.
The above findings indicate that existing normalization methods for RNA-seq data, all
developed based on FF or like samples, are ill-suited for FFPE samples as they cannot
cope with the highly complex features of such data. We proceed to develop a robust
yet powerful method, MIXnorm, based on a two-component mixture model to capture the
distinct bimodality as well as major mean and variance structures underlying the data.
The first component is to model non-expressed genes, whose read counts should be
zero or relatively small due to non-specific binding. These genes include biologically
zero-expression genes that may exist, or those with low expression but cannot be ex-
pressed due to various experimental limitations (e.g., drop-outs), or those that should be
expressed but cannot because of high-level mRNA degradation. For the non-expressed
genes, we use a zero inflated Poisson (ZIP) distribution to capture the spike at zero for
each sample, of which the Poisson mean reflects the background noise level. The second
component is to model expressed genes, and we use a truncated normal (TN) distribution
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for log gene read counts of each sample to approximate the roughly bell-shaped curve
centered at the second mode.
1.3. The MIXnorm Method
1.3.1. The statistical model for FFPE data
Let Cij denote the raw count of gene j from sample i and Lij ≡ log(Cij + 1) is the
natural logarithm transformed count, for i = 1, . . . , I, j = 1, . . . , J . We define a latent
binary variable Dj: Dj = 0 indicates gene j is non-expressed in this study, meaning that
observed non-zero counts of gene j are due to background noise; Dj = 1 indicates gene
j is expressed, with mean expression greater than 0. The following mixture model is
proposed for FFPE data:
Cij ∼ ZIP(πj, δi), if Dj = 0, (1.1)
Lij ∼ TN(µi, σ2i , 0,+∞), if Dj = 1, (1.2)
Dj ∼ Bernoulli(φ),
where 0 ≤ πj, φ ≤ 1, δi, σi > 0 for i = 1, ..., I, j = 1, ...J . Here, ZIP(πj, δi) stands for
a zero inflated Poisson distribution, with probability πj being zero and probability 1 − πj
being from a Poisson distribution with mean δi; TN(µi, σ2i ; 0,+∞) stands for a normal
distribution with mean µi and variance σ2i , left truncated at zero as Lij > 0; and φ is
the proportion of expressed genes in the study. Figure 1.1(a) clearly shows the zero-
count proportion varies across different genes, and so πj is assumed to be gene-specific
instead of being constant. The δi reflects sample-specific background noise and should
be relatively small. Figure 1.1(c) shows that the location and spread of Lij both vary
a lot from sample to sample, meaning that the sample-specific mean µi and variance
σ2i are necessary for FFPE data. We note that Lij is a discrete random variable with
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support {0, log(1), log(2), ...}, but in (1.2), a continuous distribution is used to approximate
the discrete distribution of Lij.
Let Θ = (π, δ,µ,σ, φ) denote the collection of all the parameters in the mixture model,
where π = (π1, ..., πJ), δ = (δ1, ..., δI), µ = (µ1, ..., µI) and σ = (σ1, ..., σI). The (incom-
plete) likelihood function is
L(Θ|C) =
J∏
j=1
p(Cj|Θ)
=
J∏
j=1
[p(Cj|Dj = 1,µ,σ)p(Dj = 1|φ)
+ p(Cj|Dj = 0, πj, δ)p(Dj = 0|φ)]
=
J∏
j=1
[
I∏
i=1
p(Cij|Dj = 1, µi, σi) · φ
+
I∏
i=1
p(Cij|Dj = 0, πj, δi) · (1− φ)],
where p(Cij|Dj = 0, πj, δi) is the probability mass function (PMF) of Cij of non-expressed
genes, i.e., the zero-inflated Poisson distribution in (1.1); p(Cij|Dj = 1, µi, σi) is the PMF
of Cij for expressed genes, which will be approximated by a probability density function
(PDF) with log(Cij + 1) following the TN distribution on [0,+∞) in (1.2). See Appendix A.1
for a detailed justification about the validity of using the PDF to approximate the PMF.
1.3.2. Model fitting via an EM algorithm
A common method for estimating parameters of a model with a latent variable structure
is to employ an EM algorithm [9] to obtain their maximum likelihood estimates (MLEs).
The complete-data log-likelihood with the latent variables D is given by
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`(Θ|C,D) =
J∑
j=1
log p(Cj, Dj|Θ)
=
J∑
j=1
Dj · {log(φ) + log [p(Cj|Dj = 1,µ,σ)]}
+
J∑
j=1
(1−Dj) · {log(1− φ) + log [p(Cj|Dj = 0, πj, δ)]} . (1.3)
Let Θ(t) = (π(t), δ(t),µ(t),σ(t), φ(t)) be the parameter estimates at the tth iteration. The
distribution of D given the observed data C and the current parameter estimates Θ(t) is
p(D|C,Θ(t)) =
J∏
j=1
p(Cj, Dj|Θ(t))
p(Cj|Θ(t))
=
J∏
j=1
(
w
(t)
j
)Dj (
1− w(t)j
)1−Dj
,
where
w
(t)
j =
φ(t)p(Cj|Dj = 1,µ(t),σ(t))
φ(t)p(Cj|Dj = 1,µ(t),σ(t)) + (1− φ(t))p(Cj|Dj = 0, π(t)j , δ(t))
. (1.4)
Each iteration of an EM algorithm consists of two steps, the expectation (E) step and
the maximization (M) step. The E step calculates the expected complete-data log likeli-
hood given C and Θ(t), where the expectation is taken over the latent variables D. Since
l(Θ|C,D) in (1.3) is linear in Dj, and E(Dj|C,Θ(t)) = w(t)j , we have
Q(Θ|Θ(t)) = ED|C,Θ(t)l(Θ|C,D)
=
J∑
j=1
(1− w(t)j ) [log(1− φ) + log p(Cj|Dj = 0, πj, δ)]
+
J∑
j=1
w
(t)
j [log(φ) + log p(Cj|Dj = 1,µ,σ)] . (1.5)
In essence, the E step calculates the conditional expectation of D given C and Θ(t).
The M step updates the parameter estimates by maximizing the expected log likelihood
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(1.5). Note that (1.5) can be maximized with respect to φ, (µ,σ) and (π, δ) separately.
The updated parameter estimates in the (t+ 1)th iteration are given by
φ(t+1) =
∑J
j=1w
(t)
j
J
,
(µ
(t+1)
i , σ
(t+1)
i ) = arg max
µi,σi
J∑
j=1
log TN(Lij|µi, σi, 0,∞) · w(t)j , i = 1, ..., I, (1.6)
(
π(t+1), δ(t+1)
)
= arg max
π,δ
J∑
j=1
I∑
i=1
[
log ZIP(Cij|πj, δi) ·
(
1− w(t)j
)]
, (1.7)
where the maximization in (1.7) has constraints πj ∈ [0, 1] and δi > 0; TN(·|·) stands for
the pdf of the TN distribution, ZIP(·|·) stands for the pmf of the ZIP distribution, both with
distributional parameters specified after “|”. The update for φ(t+1) has a closed form. Other
parameters can be updated by a Newton-Raphson type method numerically within each
iteration t.
The pmf ZIP(Cij|πj, δi) in (1.7) cannot be factored into functions of πj and δi. Therefore,
the update of (π, δ) involves multi-dimensional optimization, which can be computationally
intensive when I + J is large, as is typical for high-throughput profiling such as RNA-seq.
Another drawback of the above algorithm is numerical instability due to the use of the
Newton-Raphson method for an approximate solution in the M step. Dempster et al. [9]
proved that for an EM-type algorithm, the (incomplete) likelihood in every iteration never
decreases as t increases. Thus, the incomplete likelihood is typically used to monitor
the convergence of the algorithm. However, this monotone convergence property does
not necessarily hold if the E or M step is not computed exactly. In such situations, the
incomplete log-likelihood may fluctuate around a fixed point for a long time. Due to this
instability, when applying the above EM algorithm to real data, we observed that it would
not converge, especially when a small tolerance value is selected to terminate the iterative
process.
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1.3.3. Review of nested EM algorithms
van Dyk [61] described how nesting two or more EM algorithms could take advan-
tage of closed form conditional expectations and lead to algorithms with both ease of
implementation and computing efficiency (i.e., fast and stable convergence). Assume the
missing data can be split into two (or more) sets Ymis 1 and Ymis 2 such that the complete
data can be expressed by Ycom = (Yobs,Ymis 1,Ymis 2), where Ymis 1 and Ymis 2 can be intro-
duced under a data augmentation scheme to aid the computation. Let Θ denote the vector
of all parameters involved, and H is the parameter space. Define the nested conditional
expectation of log-likelihood by
Q̃ (Θ|Θ1,Θ2) = E {E [l (Θ | Yobs,Ymis 1,Ymis 2) | Yobs,Ymis 1,Θ1] | Yobs,Θ2} , (1.8)
where Θ1 and Θ2 denote different realizations of Θ, and Q̃(Θ|Θ1,Θ2) is a function on
H×H×H. The outer expectation in (1.8) is taken with respect to Ymis 1 while the nested
inner expectation is taken with respect to Ymis 2. According to van Dyk [61], the tth iteration
of a nested EM algorithm repeats the following cycle K times.
Cycle k for k = 1, ..., K:
E step: compute
Q̃
(
Θ | Θ(t+
k−1
K
),Θ(t)
)
= E{E[` (Θ|Ycom) | Yobs,Ymis 1,Θ(t+
k−1
K
)]
| Yobs,Θ(t)}
M step: update the parameter estimates by
Θ(t+
k
K
) = arg max
Θ
Q̃
(
Θ | Θ(t+
k−1
K
),Θ(t)
)
.
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Upon completion of the Kth cycle, set Θ(t+1) = Θ(t+
K
K
). That is, run K cycles of the inner
EM algorithm for each iteration of the outer EM.
When the missing data structure is complex, direct calculation of E
[
`(Θ|Ycom)|Yobs,Θ(t)
]
is usually difficult. Moreover, we may not be able to directly sample from p(Ymis 1,Ymis 2|Yobs,Θ),
and thus a Monte-Carlo EM algorithm is not feasible as well. A nested EM algorithm takes
advantages of subdividing the missing data so that p(Ymis 1|Yobs,Θ) and p(Ymis 2|Yobs,Ymis 1,Θ)
are both known distributions or easy to sample directly. Theoretical properties of nested
EM algorithms have been well studied. Theorem 1 in [61] guarantees that, like EM al-
gorithms, nested EM algorithms enjoy the monotone convergence property, and so the
incomplete-data likelihood p(Yobs|Θ) can be used to detect convergence.
1.3.4. Model fitting via a nested EM algorithm
Below we introduce additional latent variables so that a nested EM-type algorithm
can be constructed to improve computational efficiency. Based on Lambert [28], a zero
inflated Poisson distribution can be thought of as a mixture of two states, the perfect zero
state and the Poisson state. Suppose we knew which zeros came from the perfect zero
state and which came from the Poisson state. That is, for a non-expressed gene j, we
define Zij = 1 when Cij is from the perfect zero state and Zij = 0 when Cij is from the
Poisson state, for i = 1, . . . I. Obviously, Zij|Dj = 0 ∼ Bernoulli(πj). Further, we augment
the truncated normal data by (hypothesized) missing observations, which borrows ideas
from Tanner and Wong [56] and McLachlan and Jones [37]. That is, the augmented data
follow a normal distribution so that the posterior distributions of the parameters or their
functions are straightforward to calculate. For sample i, apart from the observed J genes,
there are Ti unobserved genes with Dj = 1 and their log count Lij < 0, j = J+1, ..., J+Ti,
such that Lij ∼ N(µi, σi), for j = 1, ..., J + Ti. Here, the number of observations Ti falling
in (−∞, 0) is also latent. Note that we now have a quite complex latent variable structure.
However, by nesting inner EM algorithms inside an outer EM, we do not need the actual
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realizations of the unobservable random variables Ti and Lij for j = J + 1, ..., J + Ti.
To iteratively update the parameter estimates, only the conditional expectations of the
corresponding sufficient statistics are required.
A nested EM algorithm is invoked by treating Ycom = (C,D,Z,T ,Lt) as the complete
data, where T = (T1, ..., TI), and Lt is an array with elements Lij for i = 1, ..., I and
j = J + 1, ..., J + Ti. The complete-data log-likelihood is then given by
`(Θ|C,D,Z,T ,Lt) =
I∑
i=1
J∑
j=1
{
Dj[log φ+ log N(Lij|µi, σi)
− log(Cij + 1)] + (1−Dj)[log(1− φ)
+ Zij log πj + (1− Zij) log(1− πj)]
+ (1−Dj)(1− Zij)(Cij log δi − δi − logCij! )
}
+
I∑
i=1
J+Ti∑
j=J+1
[log N(Lij|µi, σi)− log(Cij + 1)].
(1.9)
Let Yobs = C be the observed data. Ymis 1 denotesD and Ymis 2 denotes the rest of the
unobserved data (Z,T ,Lt). Following the notation used in Dempster et al. [9], denote
Y
(t)
mis 1 = E(Ymis 1|Yobs,Θ(t)). It is clear from (1.9) that E(`(Θ|Ycom)|Yobs,Ymis 1,Θ(t+
k−1
K
)) is
linear in Ymis 1. Therefore, the outer E step can be simplified by computing Y
(t)
mis 1 only once
per iteration and then run K inner EM cycles with (Yobs,Y
(t)
mis 1) treated as observed data.
Specifically, the outer E step calculates w(t)j = E(Dj|C,Θ(t)), the conditional expectation
of D. Then the inner EM treats (C,w(t)) as observed data, where w(t) = (w(t)1 , ..., w
(t)
J ).
SinceZ andLt are independent, we are essentially nesting two inner EM algorithms here.
The inner E step involving Z can be simplified to calculate the conditional expectation of
Zij given (C,w(t),Θ(t+
k−1
K
)) by noting that the complete-data log-likelihood (1.9) is linear in
Zij and
∑I
i=1 Zij is the complete-data sufficient statistic for πj. The inner E step involving
Lt and T calculates the expected values of the sufficient statistics si =
∑J+Ti
j=1 DjLij
and Si =
∑J+Ti
j=1 DjL
2
ij for the normal distribution parameters (µi, σi) conditioning on the
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observed data, w(t) and Θ(t+
k−1
K
). For detailed steps of our nested EM algorithm, see
Appendix A.2.
Compared to (1.6) and (1.7), the nested EM algorithm greatly simplifies the process of
updating (π, δ,µ,σ) by providing closed-form formulas and so avoids the need for high-
dimension optimization as well as the issue of numerical instability.
Finally, we need to determine the number of cycles K in each EM iteration. Note that
the purpose of the inner EM cycles is not to reach convergence, but rather to move quickly
towards the mode of the incomplete-data log-likelihood with a small computational cost.
Because EM algorithms usually make a significant progress in the first few iterations, van
Dyk [61] suggested to fixK at some small value. We chooseK = 5 in our implementation.
1.3.5. Normalizing gene expression and identifying expressed genes
Once the mixture model is fitted and the MLE Θ̂ is obtained from the nested EM algo-
rithm, the normalized expression Nij of gene j from sample i can be obtained by
Nij = E
(
Dj|Cj, Θ̂
)
×
Lij −
µ̂i + ψ
(
− µ̂i
σ̂i
)
Φ
(
− µ̂i
σ̂i
) σ̂i
 ,
where E
(
Dj|Cj, Θ̂
)
is calculated by (1.4) from the last E step which estimates the prob-
ability of gene j being expressed, and the term in the braces is the estimated expression
for an expressed gene after removing the sample-specific effect. Clearly, the normalized
expression is in the log scale. It is easy to use MIXnorm for detecting expressed genes.
Gene j is identified as expressed if w(t)j > cw at convergence, where cw ∈ [0, 1] is a cut-off
value. As shown in Table A.1 in Appendix A.3.2, the choice of cw seems not to have a
noticeable impact on the classification performance of MIXnorm. In fact, w(t)j in (1.4) is
determined by the ratio of p(Cj|Dj = 1,µ(t),σ(t)) and p(Cj|Dj = 0, π(t)j , δ(t)), which are
the likelihoods of the data modeled by TN and ZIP distributions, respectively. These two
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likelihoods are usually separate well. Thus, it is not surprising for us to observe that in
our simulations, w(t)j was either close to zero or close to one when MIXnorm converges,
and so different threshold values in a quite wide range would not affect the detection per-
formance much. We mention that MIXnorm is directly applicable to FF or like samples.
This is because FF samples may be viewed as a reduced case of FFPE samples (i.e.,
little degradation in FF samples compared to severe and diverse degradation in FFPE
samples). However, it is inappropriate to apply existing methods to FFPE data as they do
not have the capacity to deal with the more complex data structure, as mentioned in the
introduction.
1.4. Results
1.4.1. Simulation
Simulation studies were conducted to compare MIXnorm with five methods commonly
used for normalizing RNA-seq data, including Upper Quartile (UQ), PoissonSeq (PS),
DEseq, Reads Per Million (RPM) and trimmed mean of M values (TMM). Here, we used
a data-generating model that is modified from the proposed mixture model, in order to
better mimic real situations. In our six simulation studies, we examined the impact of the
proportion of expressed genes on the normalization performance in study I, the impacts of
the sample-specific effects in study II, the impacts of the gene-specific effects in study III,
the sensitivity to violations of model assumptions in study IV, the performance of directly
and separately applying MIXnorm when differential expressed (DE) genes exist across
different conditions in study V, and the relationship between the sample size (number of
genes) and computing time of MIXnorm in study VI. For details about the data-generating
models, process and simulation settings, see Appendix A.3.1. All the results are reported
and discussed in Appendix A.3.2. We find that MIXnorm consistently outperforms the
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existing methods in nearly all the settings and is more robust to changes of sample-
specific or gene-specific effects as well as violations of model assumptions. We also find
that the computing time of MIXnorm has almost a perfect positive linear relationship with
the sample size and number of genes, respectively. When DE genes exist, we recommend
applying MIXnorm to normalize data from different groups separately instead of applying
it to pooled data.
1.4.2. Data application
Soft tissue sarcomas data. The soft tissue sarcomas dataset was used for our ex-
ploratory analysis in Section 1.2, which contains expression levels for 20, 242 protein cod-
ing genes from paired FF and FFPE samples of 41 patients measured by RNA-seq. Note
that the availability of paired FF samples would enable us to quantitatively assess and
compare the performance of different RNA-seq normalization methods. Since the true
(normalized) gene expression is unknown, it is generally difficult to compare the perfor-
mance on real data. Nevertheless, such paired FF data, after normalization to remove
technical effects, can be used as a surrogate of the truth. This is because FF tissues
are known to maintain RNA very well (much lower degradation of RNA and no methylene
crosslink between RNA and proteins) and thus are considered as a gold standard for most
molecular assays [52]. To be specific, the gene-wise Pearson correlations between nor-
malized FFPE and FF data (in the log scale) were computed and compared among the
six different methods (MIXnorm, DEseq, RPM, TMM, PS and UQ). The correlations be-
tween original FFPE and FF data (without using any normalization method, also in the log
scale) were computed to provide a baseline. We used the same approach as described
in Appendix A.3.2 to deal with genes that have zero standard deviations when computing
Pearson correlations.
Since the soft tissue sarcomas data were collected primarily for the analysis of the
CINSARC gene signature, we evaluated the performance on all the 20, 242 genes as well
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Table 1.1: Data applications: the left and middle panels show gene-wise correlations
between normalized FFPE and FF expression for soft tissue sarcomas data; the right
panel shows gene-wise correlations between normalized FFPE and RNAlater expression
for ccRCC data. The Upper-Quartile method (UQ) failed to work for soft tissue sarcomas
data due to excess zeros.
Method
Soft tissue sarcomas ccRCC
CINSARC gene signature 20,242 protein coding genes 18, 458 protein coding genes
1st. Qu. Median 3rd. Qu. 1st. Qu. Median 3rd. Qu. 1st. Qu. Median 3rd. Qu.
MIXnorm 0.333 0.455 0.517 0.098 0.235 0.384 0.304 0.524 0.789
DEseq 0.165 0.260 0.354 0.019 0.160 0.298 0.203 0.418 0.609
RPM 0.146 0.243 0.350 0.010 0.156 0.297 0.204 0.422 0.612
TMM 0.010 0.098 0.161 0.021 0.159 0.291 0.110 0.267 0.463
PS -0.126 0.002 0.154 -0.374 -0.148 0.036 0.071 0.285 0.491
UQ - - - - - - 0.187 0.407 0.610
Original 0.020 0.107 0.181 0.011 0.146 0.277 0.142 0.299 0.485
as the 67 genes in the gene signature. Table 1.1 summarized gene-wise correlations for
the CINSARC gene signature in the left panel, and gene-wise correlations for all the genes
in the middle panel, where genes in the CINSARC signature show considerably higher
correlations than the population of the protein coding genes for the methods MIXnorm,
DESeq, and RPM. Among all the methods, MIXnorm results in the highest quartiles.
DEseq is the second best in this real data application, which is also one of the recom-
mended normalization methods for high-throughput RNA sequencing data [11]. The most
straightforward normalization method RPM gives better result compared to PoissonSeq
and TMM for genes in the CINSARC signature. UQ failed to normalize the data. After re-
moving genes with zero raw read counts across all samples, there are still several FFPE
samples with more than 75% zero counts, which makes the scaling factors of UQ equal
zero. Note that for DEseq, genes with at least one zero read count were removed before
calculating the scaling factors, which removed 97% of genes in the FFPE RNA-seq data.
Figure 1.2 plots the normalized FFPE and FF expression levels in the log scale for all
67 genes in the CINSARC signature, where the left panel shows scatterplots for MIXnorm,
TMM and DESeq, and the right panel shows scatterplots for RPM, PS and the original
data. We observe that all these genes were identified as expressed genes by MIXnorm,
16
as one may expect. For all methods except MIXnorm, there are genes whose normalized
FF expression is high but normalized FFPE expression is low or almost zero, resulting
in an obvious horizontal line at y = 0. This suggests that the existing methods were not
able to handle genes with zero or low expression well in FFPE samples. The Pearson
correlation coefficients between normalized FF and FFPE expression levels reported in
Figure 1.2 also indicate that MIXnorm has the best overall performance for this gene
signature.
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Figure 1.2: Soft tissue sarcomas data example: the normalized FFPE vs. FF expressions
in the log scale from all 41 samples for all 67 genes in the CINSARC gene signature. The
left panel shows scatterplots for MIXnorm, TMM and DESeq, and the right panel shows
scatterplots for RPM, PS and the original data (without any normalization). Pearson cor-
relation coefficients are reported for each method in the legend.
Clear cell renal cell carcinoma (ccRCC) data. Our second application uses the
ccRCC dataset from Eikrem et al. [13], of which RNA-seq data from FFPE samples were
used to simulate synthetic data in Section 1.4.1. ccRCC is the most common subtype
of renal cell carcinoma, and is resistant to conventional chemotherapy and radiotherapy.
Therefore, it is only curable by early surgical tumor removal when a surgery is able to
eradicate the disease. Reversal of cancer gene expression is predictive of therapeutic
potential. Much effort has been made to develop molecular signatures of disease progres-
sion for ccRCC. Among many, Eikrem et al. [13] aimed to validate RNA-seq outcomes
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from FFPE biopsies with paired RNAlater stored samples for ccRCC patients. The data
include 16 adult patients from Haukeland University Hospital. Four core biopsies were ob-
tained from each patient, including two with ccRCC and two from adjacent normal tissues.
The two pairs of ccRCC and normal tissues were then stored in FFPE and RNAlater, re-
spectively. The RNA-seq data obtained from these tissues contain genes annotated by
Ensembl. We converted the Ensembl ID to the HGNC symbol by Biomart and kept the
protein coding genes only. The processed dataset contains 18, 458 protein coding genes
and 32 paired FFPE and RNAlater samples.
The proposed MIXnorm model in Section 1.3.1 is quite general, we believe. In prac-
tice, however, model assumptions (mainly, zero inflation and truncated normality) may
not roughly hold. Thus, before applying MIXnorm to RNA-seq data, we recommend that
users conduct an explanatory analysis as we did for the soft tissue sarcomas data us-
ing log transformed read counts (i.e., Figures 1.1), and look for clear bimodality with the
first spike occurring at zero and approximately Gaussian curves around the second mode
for most samples. The empirical densities of log read counts for the 32 paired FFPE
and RNAlater samples, shown in Figure A.7 of Appendix A.4, suggest the suitability of
the proposed MIXnorm for the ccRCC data. We also suggest conducting a confirmatory
analysis after applying MIXnorm, by visually examining Q-Q plots or conducting distri-
butional tests, to check whether the assumption of truncated normality is adequate for
expressed genes in most of the samples. Both Q-Q plots (Figure A.8) and p-values from
Kullback-Leibler tests (Figure A.9) suggest that there was no gross departure from the
assumed TN distributions for ccRCC FFPE data. For detail, see Appendix A.4.
RNAlater is an aqueous, non-toxic tissue storage reagent that rapidly permeates tis-
sues to stabilize and protect cellular RNA in unfrozen specimens. It is considered to
be comparable to the fresh frozen procedure. Therefore, the normalized RNAlater data
were used as a surrogate of the gold standard in this application. The 18, 458 gene-wise
Pearson correlations between normalized FFPE and RNAlater data in the log scale were
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computed to evaluate the performance. As suggested in Section 1.4.1, we performed
MIXnorm separately on the tumor and normal tissues. The gene-wise correlations were
then calculated from all 32 paired samples. The quartiles and median of the correla-
tions are summarized in the right panel of Table 1.1. Compared to the original data, the
MIXnorm, DEseq, RPM and UQ normalized data improve the gene-wise Pearson corre-
lations. Clearly, MIXnorm performs the best among all methods. DEseq, RPM and UQ
have similar quartiles in this application. We note that the ccRCC FFPE data have bet-
ter quality compared to the soft tissue sarcomas FFPE data. In fact, DEseq only needs
to remove 32% of genes that have zero raw read counts. UQ needs to remove 5% of
genes with zero raw read counts across all samples. Obviously, the performance of the
quantile-based methods heavily depends on the data quality. Further, in real applications
with FFPE samples, none of the existing normalization methods is robust while MIXnorm
seems to be superior. After all, only MIXnorm is specifically designed for FFPE RNA-seq
data.
As requested by one of the reviewers, we provide additional results in Table A.2 of
Appendix A.4 to investigate the impact of removing genes with low expression on the per-
formance of different normalization methods. We find that MIXnorm gives similar results
regardless of removal of such genes or not, and maintains its top performance.
This paired design allows us to conduct differential expression analysis between ccRCC
and normal conditions using both FFPE and RNAlater samples, and to access the valid-
ity of using FFPE samples for such analysis. We identified differentially expressed (DE)
genes (Benjamini-Hochberg adjusted p value < 0.05 from paired t-tests and absolute log2
fold change > 2) from each of the two tissue sources based on the different normalization
methods and report results in Table 1.2. We find that MIXnorm gives the highest number
of common DE genes from the two sources. Furthermore, among the two sets of top
20 DE genes identified from RNAlater and FFPE samples, MIXnorm gives the highest
number (13) of common genes while the other methods gives 9 or less. Table 1.3 sum-
19
marizes the FFPE and RNAlater log2 fold changes (FCs) of 13 shared genes identified
by MIXnorm, of which Spearman correlation is 0.88.
Table 1.2: ccRCC data example: summary of differential expression analysis based on
different normalization methods. The second column is the number of DE genes identified
from the FFPE data; the third column is the number of DE genes identified from the
RNAlater data; the fourth column is the number of common genes between the two sets
of DE genes; the last column is the number of common genes among the two sets of top
20 DE genes from FFPE and RNAlater.
FFPE RNAlater Common Common
DE genes DE genes DE genes top 20 DE
MIXnorm 1488 1482 1036 13
DEseq 1014 951 680 7
RPM 999 926 676 9
TMM 1073 1067 632 7
PS 1001 1300 652 8
UQ 1002 943 679 8
Original 1041 1096 646 9
Table 1.3: ccRCC data example: the 13 shared genes among the two sets of top 20 DE
genes from FFPE and RNAlater, ordered by the absolute value of the RNAlater log2 FC.
CA9 SLC6A3 NDUFA4L2 UMOD GP2 CLCNKA CDCA2 TNFAIP6 SLC4A11 KNG1 SLC12A1 AQP2 NELL1
RNAlater log2 FC 8.04 7.22 6.39 -6.15 -5.51 -5.28 5.23 5.17 -5.08 -5.02 -4.95 -4.92 -4.77
FFPE log2 FC 5.66 6.31 4.89 -5.62 -4.96 -5.69 5.05 5.45 -5.22 -5.03 -4.89 -4.89 -5.02
Table 1.3 confirms strong over-expression of SLC6A3 and CA9 and under-expression
of UMOD and SLC12A1 in ccRCC tissues, previously identified by immunohistochem-
istry studies [13, 51, 65]. The normalized expression levels of the four genes from FFPE
samples are plotted in Figure 1.3, which clearly show the up- and down-regulation of
these genes. It is interesting to note that the most up-regulated gene SLC6A3 identified
by FFPE data is associated with the process of producing dopamine transporter (DAT).
The importance of expression changes of DAT has been widely studied in Parkinson’s
syndrome and attention-deficit/hyperactivity disorder (ADHD) [40, 51]. Recently, Hans-
son et al. [21] studied fresh frozen samples from The Cancer Genome Atlas (TCGA)
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Figure 1.3: ccRCC data example: normalized expressions levels of CA9 (Panel A),
SLC6A3 (Panel B), UMOD (Panel C) and SLC12A1 (Panel D) from FFPE samples.
database and identified the DAT SLC6A3 as a specific biomarker for ccRCC. Our applica-
tion demonstrates that SLC6A3 expression measured from FFPE samples may also serve
as a highly specific biomarker for ccRCC. Tostain et al. [57] presented a comprehensive
study on the Carbonic anhydrase 9 (CA9) as a marker for diagnosis, prognosis and treat-
ment in ccRCC. It has been shown that CA9 mRNA expression measured by reverse
transcription polymerase chain reaction (RT-PCR) and CA9 antigen detected by ELISA
are promising molecular markers for diagnosis and prognosis of ccRCC [57]. Our analy-
sis further suggests that CA9 expression measured from FFPE RNA-seq may also serve
as a molecular marker for ccRCC. It is worth noting that among the common top 20 DE
genes, all normalization methods except MIXnorm failed to identify SLC12A1. SLC12A1
is a protein coding gene that encodes kidney specific sodium-potassium-chloride cotrans-
porter and is known to be associated with Bartter Syndrome and Antenatal Bartter Syn-
drome. Schrödter et al. [51] found that SLC12A1 expression was decreased in FF ccRCC
tissues. Our analysis finds that after MIXnorm normalization, FFPE tissues are also able
to detect down-regulation of SLC12A1.
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1.5. Discussion
In recent years, many studies have been conducted to evaluate the feasibility of us-
ing FFPE specimens with RNA-seq, the dominant high-throughput technology in gene
expression profiling. These studies have collectively provided overwhelming evidence of
reliable expression profiles obtained from FFPE specimens. However, none of the exist-
ing methods was developed for normalizing FFPE RNA-Seq data, a critical step in data
analysis. Motivated by real data from FFPE tissues, we developed a two-component mix-
ture model, which intends to capture major characteristics of the FFPE RNA-seq data
accurately. Due to the resulting complex likelihood function, direct maximization can be
unrealistic and time-consuming. By designing a nested EM-type algorithm that is easy
to implement and computationally efficient, we greatly reduced the difficulty of finding the
MLE.
We have shown that MIXnorm maintains top performance across various simulation
settings and in two real data applications, compared to five existing RNA-seq normaliza-
tion methods. The advantage of MIXnorm becomes more significant when the proportion
of expressed genes becomes small. This may be due to the fact that MIXnorm is able to
identify expressed genes from non-expressed genes accurately, and then models the two
groups separately by ZIP and TN distributions. Besides the improvement in performance,
MIXnorm has two other merits: (i) it handles genes with high-proportion zeros rigorously
while existing methods typically require removal of such genes beforehand; (ii) it can out-
put a parameter that represents the proportion of expressed genes, which can serve as
an overall quality score for an RNA-seq experiment using FFPE tissues.
In MIXnorm, we employed zero-inflated Poisson (ZIP) instead of zero-inflated Negative
Binomial (ZINB) distributions to model non-expressed genes. This is mainly because
after sorting out expressed genes, over-dispersion would not be a major issue. Also,
NB and Poisson models often give similar parameter estimates, and NB fitting leads to
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larger standard error (SE) estimates than Poisson fitting. However, for the purpose of
normalization, the SE estimates would not affect the results. Thus, ZIP was used also for
simplicity.
We mention that FF data show simpler patterns than FFPE data, which can be mod-
eled by simplifying the FFPE model proposed in Section 1.3, i.e., setting σ2i ≡ σ2 in (1.2),
as Fig 1.1(d) shows a constant variance of Lij across samples. In our soft tissue sarco-
mas data example, the estimated SDs of the TN distributions are much more consistent
for the FF samples (coefficient of variation CV = 0.05) than those for the FFPE samples
(CV = 0.40). That’s why one can apply MIXnorm directly to FF or like samples, as dis-
cussed in Section 1.3.5. However, for computational efficiency, we can further simplify the
nested EM algorithm to accommodate a common variance σ2, to be able to run faster for
FF data.
Single-cell RNA-sequencing (scRNA-seq) has become widely used for transcriptome
analysis in many biological studies. Like FFPE RNA-Seq data, scRNA-seq data have the
sparsity feature. However, we do not recommend that MIXnorm be applied to such data
blindly. scRNA-seq experiments aim to capture the heterogeneity among individual cells,
where different cell types or transient states may make a gene expressed only in some
cell subpopulations [59]. As discussed in the introduction, commonly used normalization
methods for bulk RNA-seq data (eg., DEseq, TMM, PS, UQ, etc.) are typically based
on scaling factors, which assume that most of the genes are not differently expressed
across different samples in a study [1, 49]. Obviously, this key assumption is not valid
for scRNA-seq data. We note that MIXnorm is essentially a scaling factor based method,
too. The scaling factor for each sample is estimated by the mean of the sample-specific
TN distribution. In particular, MIXnorm assumes that a gene is either expressed or not
across all samples in a study, which is invalid for scRNA-seq data. Thus, we believe that
MIXnorm is not suitable for normalizing scRNA-seq data.
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CHAPTER 2
SMIXnorm: Fast and Accurate RNA-seq Data Normalization for Formalin-Fixed
2.1. Introduction
The application of next-generation sequencing (NGS) on measuring transcript abun-
dance is widely known as RNA-seq. RNA-seq works by sequencing a library of cDNA
fragments in a high-throughput manner in order to provide a comprehensive quantifica-
tion of transcriptomic activities in biological samples [45]. In practice, normalization is an
important step in RNA-seq data analysis since raw counts are often not directly compara-
ble between samples [11]. Normalization brings out the biologically relevant information in
gene expression by removing the systematic noise that arises from various experimental
reasons (such as batch effect, lane effect, sequencing bias, etc.). Recent studies have
shown that the raw sequencing data without normalization could cause invalid inference
from many conventional statistical analyses and measurements [45].
Fresh-frozen (FF) tissue biospecimens are considered the gold standard in molecular
analysis using gene expression, as freezing preserves RNA well. A number of normaliza-
tion methods have been well studied on FF bulk RNA-seq data [11]. Most existing meth-
ods, including Reads Per Million (RPM), Upper-Quartile (UQ), DESeq, Trimmed Mean
of M-values (TMM), etc., are based on scaling factor estimation, where the normalized
expression is obtained by dividing the raw count by an estimate of the sample-specific
scaling factor. For example, RPM [38] estimates the scaling factor for each sample by
the total number of reads divided by 1, 000, 000. Similarly, UQ [4] estimates the scaling
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Paraffin-Embedded Samples
factor by the upper quartile of counts across all genes for each sample. DESeq [1] nor-
malization first calculates the geometric means of the counts for all genes as an average
reference library. Then the ratio of the count in each sample to that in the reference library
is computed. The scaling factor for each sample is estimated as the median of this ratio
across all genes. TMM [49] normalization selects one sample as a reference, and the M
values are calculated as the log ratios of the read count between each test sample and
the reference for all genes. Then for each test sample, the scaling factor is estimated by
the weighted mean of M values after removing the genes with extreme average expres-
sion or M values. On the other hand, normalization can be done implicitly by accounting
for the size factor as a term in the RNA-seq data model. PoissonSeq (PS) [31] models
RNA-seq data by a Poisson log-linear model, where a set of sample-specific parameters
is included as offset parameters in the linear predictor to account for different sequencing
depths.
Recently, there has been increasing interest in performing transcriptome profiling on
Formalin-Fixed Paraffin-Embedded (FFPE) tissues, as they are widely available from rou-
tine diagnostic sample preparation [39]. Being able to successfully measure mRNA abun-
dance from FFPE samples could greatly facilitate biomarker discoveries and genomic
studies of clinical samples [19, 20]. The major challenge of adapting FFPE biospeci-
mens in molecular analysis is that the chemical process is designed to preserve cellular
proteins rather than preserving RNA. As a result, RNA from FFPE tissues is usually de-
graded, which could limit gene expression analysis. Studies have shown that the fixation
process, storage time, specimen size and conditions play important roles in the RNA
quality from FFPE samples [63]. Although such samples may suffer from the chemical
modifications and continued degradation over time, recent studies have shown that RNA-
seq can measure the RNA expression from FFPE samples in sufficient quality [32]. Due
to chemical modifications and the RNA degradation, the RNA quality and abundance ex-
tracted from the FFPE samples vary a lot. Therefore, the normalization step is even more
important for RNA-seq data measured from FFPE samples than those measured from
25
FF samples. However, none of the existing methods were specifically designed and val-
idated on FFPE samples. The mRNA expression measured from FFPE can have lower
quality and higher sparsity (i.e. many zero counts occur), compared with FF samples.
Consequently, the zero-inflation makes the assumption of model-based FF RNA-seq nor-
malization invalid. For most scaling factor-based RNA-seq normalization, practitioners
need to discard genes with many zeros beforehand, which may be a significant portion of
the data when applied to FFPE samples. To the best of our knowledge, MIXnorm [67] is
the only method that is designed to normalize FFPE RNA-seq data but that is applicable
to FF RNA-seq data as well. MIXnorm addresses the zero inflation by separately mod-
eling the expressed genes and non-expressed genes in a mixture model. It consistently
outperforms commonly used FF RNA-seq normalization methods. However, MIXnorm
relies on a complex latent variable structure for model fitting, which causes a heavy com-
putational burden for large data sets. We show in this paper that the statistical model of
MIXnorm can be properly simplified to still capture the main characteristics of the FFPE
RNA-seq data. We propose a simplified version of MIXnorm, labeled SMIXnorm, for FFPE
RNA-seq data normalization. The fitting of SMIXnorm requires a less complicated latent
variable structure. We show through simulation studies and real data applications that
SMIXnorm retains almost the same performance as MIXnorm, while greatly reducing the
computing time.
More importantly, there is a lack of platforms that integrate existing methods and pro-
duce normalized data by different methods. Evans et al. [15] mentioned that the selection
of normalization methods played an important role in downstream analysis due to the dif-
ferent assumptions those methods made. Furthermore, it is important to raise the aware-
ness of the separate normalization methods for FFPE samples, as more and more appli-
cations involve RNA-seq data from such samples. We developed a web portal, RNA-seq
Normalization (RSeqNorm) (http://lce.biohpc.swmed.edu/rseqnorm/), to conduct normal-
ization for both FF and FFPE RNA-seq data. It offers seven normalization methods, with
accompanying diagnostic plots for users to visually examine the RNA-seq data quality.
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Based on this platform, we compared different normalization methods using both com-
prehensive simulation studies and real data applications. These results, together with
the RSeqNorm web portal, will facilitate users to select the best normalization method for
their application.
The paper is structured as follows. In Section 2.2.1, we present the SMIXnorm method.
The statistical model of SMIXnorm is simplified from that of MIXnorm. An efficient nested
Expectation-Maximization (EM) algorithm is designed for model fitting. We further justify
the simplifications by comparing SMIXnorm to MIXnorm from a technical point of view.
An introduction of the web portal RSeqNorm is given in Section 2.2.2. Section 2.3 reports
simulation studies and real data analyses. Finally, a brief concluding discussion is made
in Section 2.4.
2.2. Materials and methods
2.2.1. The SMIXnorm method
The simplified statistical model. Assume the RNA-seq count data from FFPE sam-
ples can be summarized by a matrix CI×J , where Cij is the number of reads in sample
i for gene j. We adopt a similar latent variable framework as in MIXnorm to address the
zero inflation of such data. That is, the binary latent variable Dj = 1 indicates gene j
is expressed and Dj = 0 indicates gene j is not expressed in the study for j = 1, ..., J .
Then we model the count data as a mixture of zero-inflated Poisson (ZIP) and normal
distributions,
Cij ∼ ZIP(πj, δ), if Dj = 0, (2.1)
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Lij ∼ N (µi, σ2i ), if Dj = 1, (2.2)
Dj ∼ Ber(φ),
where Lij = log(Cij + 1) denotes the log transformed count, 0 ≤ πj, φ ≤ 1, δ, µi, σi ≥ 0 for
i = 1, ..., I and j = 1, ...J . The model assumes an unobserved variable Dj which follows a
Bernoulli distribution with parameter φ. Genes with Dj = 0 are considered not expressed.
These include low-expression genes that have abundance below detection limit, or bio-
logically non-expressed genes that are absent from the biological sample of interest, or
genes that should have been expressed but suffer from high-level mRNA degradation.
The observed counts from non-expressed genes are due to background noise and are
modeled by a zero-inflated Poisson distribution with gene-specific probability of extra ze-
ros πj and a common expected Poisson count δ. Genes with Dj = 1 are expressed genes
and we model the log counts of those genes by a normal distribution with sample-specific
location and scale parameters. Compared to the model of MIXnorm, we use the nor-
mal distribution in (2.2) instead of a truncated normal distribution and a common Poisson
mean δ rather than the sample-specific mean δi. As will be discussed in the following
section, these would greatly facilitate the computation while not hurting much the perfor-
mance. Note that the normal distribution assigns positive densities to negative log counts
Lij, which never occur in real data. However, it is reasonable to assume that the negative
values only take a negligible portion of the density in modeling expressed genes as the
mean (log) counts of such genes are usually well above zero. Further, SMIXnorm is di-
rectly applicable to FF or like samples based on the same argument in Yin et al. [67] that
FF samples may be considered a reduced case of FFPE samples.
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Model fitting. Let Θ = (µ,σ,π, δ, φ) denote the set of all parameters in the simplified
model. The observed data likelihood as a function of Θ is defined as follow:
L(Θ|C) =
J∏
j=1
p(Cj|Θ)
=
J∏
j=1
[p(Cj|Dj = 1,µ,σ)p(Dj = 1|φ)
+ p(Cj|Dj = 0, πj, δ)p(Dj = 0|φ)]
=
J∏
j=1
[
I∏
i=1
p(Cij|Dj = 1, µi, σi) · φ
+
I∏
i=1
p(Cij|Dj = 0, πj, δ) · (1− φ)], (2.3)
where p(Cij|Dj = 1, µi, σi) is the probability density function (pdf) of Cij for expressed
genes such that log(Cij+1) follows the normal distribution in (2.2), and p(Cij|Dj = 0, πj, δ)
is the zero-inflated Poisson probability mass function (pmf) for non-expressed genes as
described in (2.1). Note that a continuous distribution is used to approximately model the
discrete random variable log(Cij + 1). See Yin et al. [67] for a detailed justification for the
approximation.
A common approach to obtain the maximum likelihood estimate (MLE) of Θ is to treat
(C,D) as the complete data and update the parameter estimates iteratively by an EM
algorithm. However, direct implementation of the EM algorithm requires Newton-Raphson
type maximization to update the parameters within the ZIP component, which may cause
the EM algorithm fail to converge due to numerical instability. By a similar approach in
Yin et al. [67], we update the parameter estimates from the ZIP component by nesting
another EM algorithm and avoid the Newton-Raphson type optimization. Specifically, we
construct another latent variable Zij for genes not expressed so that the ZIP distribution
can be treated as a mixture of two states, the perfect zero state and the Poisson state.
Assume Zij = 1 when Cij is from the perfect zero state and Zij = 0 when Cij is from
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the Poisson state, satisfying Zij|Dj = 0 ∼ Ber(πj). Let Ycom = (C,D,Z) denotes the
complete data. The complete-data log-likelihood with latent variablesD and Z is given by
`(Θ|C,D,Z) =
J∑
j=1
I∑
i=1
{
Dj [log φ+ log N(Lij|µi, σi)− log(Cij + 1)]
+ (1−Dj) [log (1− φ) + Zij log πj + (1− Zij) log (1− πj)]
+ (1−Dj) (1− Zij) [Cij log δ − δ − logCij! ]
}
. (2.4)
The outer EM treatsC as observed data andD as missing data. Let Θ(t) = (µ(t),σ(t),π(t), δ(t), φ(t))
denote the set of current parameter estimates after t iterations of the algorithm. The dis-
tribution of D given the observed data and Θ(t) is
p(D|C,Θ(t)) =
J∏
j=1
p(Cj, Dj|Θ(t))
p(Cj|Θ(t))
=
J∏
j=1
(
w
(t)
j
)Dj (
1− w(t)j
)1−Dj
,
where
w
(t)
j =
φ(t)p(Cj|Dj = 1,µ(t),σ(t))
φ(t)p(Cj|Dj = 1,µ(t),σ(t)) + (1− φ(t))p(Cj|Dj = 0, π(t)j , δ(t))
. (2.5)
Note that in (2.4), the complete-data log-likelihood is linear in D. Therefore, the outer
E step, which calculates the conditional expectation of the complete-data log-likelihood
with respect to the missing data D, is reduced to computing w(t)j = E(Dj|C,Θ(t)) only
once per iteration. Within each iteration of the outer EM, the inner EM repeats K cycles
and treats Z as missing data and (C,w(t)) as observed data, where w(t) = (w(t)1 , ..., w
(t)
J ).
By the similar argument and that
∑I
i=1 Zij is the complete-data sufficient statistic for πj,
the kth cycle of the inner E step involving Z is reduced to calculating the conditional
expectation of Zij given (C,w(t),Θ(t+
k−1
K
)).
Details of the nested EM algorithm are summarized in Appendix B.1. The conver-
gence can be detected using the change of the observed-data log-likelihood `(Θ|C) in
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two consecutive iterations which is trivial to obtain via (2.3). We set the number of inner
EM cycles K = 5 within each iteration in our implementation as in Yin et al. [67].
Similar to MIXnorm, SMIXnorm normalization relies on the accurate classification of
the genes that are expressed or not. This is indicated by the latent variable Dj. We
estimate Dj by its conditional expectation given the observed data at the last E-step. As-
sume that the majority of genes are not differentially expressed across samples (Robin-
son, Oshlack 2010). Then the means of the normal distributions µi’s can be treated as
the sample-specific noises. The normalized expression for sample i and gene j can be
given by
Nij = E
(
Dj|Cj, Θ̂
)
× (Lij − µ̂i), (2.6)
where Θ̂ denotes the MLE of Θ. In our numerical experiments, when gene j is not ex-
pressed, it is often the case that the conditional expectation E
(
Dj|Cj, Θ̂
)
≈ 0, which
makes Nij ≈ 0; when gene j is expressed, E
(
Dj|Cj, Θ̂
)
is often close to 1. Thus, we
may simply output zero for genes with D̂j = 0, and Lij − µ̂i for genes with D̂j = 1 in
the actual implementation. The proposed method normalizes the data by subtracting the
estimated sample-specific noise from the log count. Therefore, the normalized data are
in the log scale.
SMIXnorm vs. MIXnorm. There are two major simplifications when comparing SMIXnorm
to MIXnorm. First, SMIXnorm assumes a common Poisson mean δ for the non-expressed
genes, where MIXnorm allows the sample-specific Poisson means δi. Note that δ ap-
pears in the normalization step (2.6) through the conditional expectation of Dj that can be
computed by equation (2.5). We observe in practice that after the nested EM algorithm
converges, the conditional expectation E(Dj|C,Θ(t)) (i.e., w(t)i in equation (2.5)) is not
sensitive to the choice of a common or sample specific Poisson mean. With the param-
eters set to their MLE, this conditional expectation mainly depends on the ratio between
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p(Cj|Dj = 0, π̂j, δ̂) (or p(Cj|Dj = 0, π̂j, δ̂i) in MIXnorm) and p(Cj|Dj = 1, µ̂, σ̂). The Pois-
son mean essentially reflects the background noise level and is supposed to be a small
positive number. Thus, the former distribution, regardless of using δ̂ or δ̂i, puts most of its
probability mass near 0, whereas the latter distribution in practice has negligible density
around small values near 0. Consequently, the conditional expectation in equation (2.5)
is close to either 1 or 0 depending on whether the gene is expressed or not and reducing
δi to δ has little effect in the normalization step.
We further simplify the model by ignoring the truncation on the normal distributions.
Compared to MIXnorm, the sample-specific noise among expressed genes is captured by
the mean of a normal distribution in SMIXnorm instead of the mean of a truncated normal
distribution. However, we argue that these two estimates are asymptotically identical. As-
sume we model a set of continuous positive real numbersX = (X1, ..., XJ) by a truncated
normal distribution TN(θ, τ 2, 0,+∞), where θ and τ are the mean and standard deviation
of the corresponding normal distribution before truncation. To estimate the mean of the
truncated normal distribution, which is a function of θ and τ , say m(θ, τ), one common
approach is to first obtain the maximum likelihood estimates (θ̂, τ̂), then the maximum
likelihood estimate of the mean is m(θ̂, τ̂) based on the invariance property of MLE. An-
other approach for a point estimate is the method of moments. The method of moments
estimate of m(θ, τ) is simply the sample mean X̄, which is essentially the MLE of µ if we
ignore the truncation and model the data with N(µ, σ2). Under the large sample situation,
as is often the case in RNA-seq data involving many genes from whole-genome experi-
ments, both m(θ̂, τ̂) and X̄ are asymptotically consistent estimators for m(θ, τ). The use
of a normal distribution without truncation is appealing since it has closed-form parameter
updates within the nested EM algorithm, while a truncated normal distribution requires
additional latent variable structures and data augmentation to obtain closed-form param-
eter updates [67]. Overall, SMIXnorm produces similar normalized expression compared
to MIXnorm whereas greatly simplifies the model fitting process, as will be confirmed in
Section 2.3 by numerical evidence.
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2.2.2. RSeqNorm web portal
The RSeqNorm web portal (http://lce.biohpc.swmed.edu/rseqnorm) provides a set of
analysis routines for normalization of RNA-seq data from either FF or FFPE samples. The
workflow is illustrated in Figure 2.1. Users provide raw sequence read count data (e.g.,
from RNA-seq experiments) in the form of an integer-valued matrix C. The web portal
can compute the normalized expression as well as diagnostic information for download.
We implement SMIXnorm, MIXnorm and five commonly used normalization methods,
including Reads Per Million (RPM), Upper-Quartile (UQ), DESeq, Trimmed Mean of M-
values (TMM) and PoissonSeq (PS). Though developed for FFPE data, SMIXnorm and
MIXnorm are directly applicable to FF data normalization. However, other methods may
cause suboptimal performance if applied to FFPE data [67]. For FF data normalization,
there seems to have no unanimously best normalization method. We suggest using the
methods offered by RSeqNorm and evaluating the normalization performance using prior
information or known biological knowledge. For example, users may conduct a differential
expression (DE) test following the normalization step and select the method that detects
more genes that are known to be differentially expressed in the literature.
RSeqNorm accepts the raw read count matrix in a comma-separated values (CSV)
file. The (i, j) element of the count matrix records how many reads have been assigned
to gene j in sample i. An example input file is downloadable from the RSeqNorm web-
site. Detailed file requirements are shown in Figure 2.2. SMIXnorm and MIXnorm require
additional input arguments including the maximum number of iterations (range (10, 50),
default value 15) and the convergence threshold (recommend range (1e − 5, 1), default
value 0.01) for the nested EM algorithm. We note that the observed-data log-likelihood
as a function of all parameters may have a large curvature near the MLE. However, the
SMIXnorm and MIXnorm normalized expression values are not sensitive to small varia-
tions of the parameter estimates. Therefore, the convergence criterion here is defined
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Figure 2.1: Summary of RSeqNorm web-portal process.
as the maximum absolute change in the parameter updates between the previous and
current iterations, instead of using the change in the observed-data log-likelihood. The
algorithm stops when the absolute change is smaller than the predetermined threshold
value or the maximum number of iterations is reached. We mentioned in Section 2.2.1
that the conditional probability of being expressed is often close to either 0 or 1. As a
consequence, the normalized expression level for a non-expressed gene is usually a triv-
ial number (<10e-10 in our implementation to real data). Therefore, an approximate set
of normalized expression is also available for SMIXnorm and MIXnorm, which normal-
izes genes with D̂j = 0 directly to 0 across all samples, where D̂j = I(w
(t)
j > cw) at
convergence, I(·) is the indicator function and cw is set to 0.5 in RSeqNorm. In practice,
we observe that the choice of cw is not sensitive in identifying expressed genes. The
conditional probability of being expressed (w(t)j ) and the proportion of expressed genes
identified (φ̂) are returned in the R package RSEQNORM, which is downloadable from
our website. Note that φ̂ may reflect the overall data quality for an RNA-seq experiment
(i.e., a value close to 1 indicates high quality).
RSeqNorm returns the normalized expression in a CSV file with the same dimension
as the user input file. User may leave the web portal after successfully submitting the
job and an email notification will be sent to the user with a download link when the nor-
malization is finished. A histogram of zero-count proportions is also returned as shown
in Figure 2.3, where SMIXnorm is used on the example data provided by RSeqNorm.
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Figure 2.2: RSeqNorm upload file requirements.
The histogram shows the distribution of zero-count proportions among all samples (rep-
resented by the horizontal axis) over all input genes. High frequencies near 0 indicate
that most biologically expressed genes are actually expressed in all samples in the exper-
iment and so the data are of high quality. Ideally, one would expect that a gene is either
expressed among all samples or not expressed in any of the samples. In this ideal case,
the histogram shows frequencies only at 0 and 1 on the horizontal axis.
2.3. Results
2.3.1. Simulation
We conducted simulation study to show that SMIXnorm greatly reduces computing
time and maintains performance comparable to MIXnorm that is better than all FF RNA-
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Figure 2.3: Diagnostic plot returned by RSeqNorm using SMIXnorm.
seq normalization methods. Our simulation study evaluates the computing time of SMIXnorm
and MIXnorm with different sample sizes. Note that the SMIXnorm model cannot be used
to simulate the data since it permits negative log transformed counts that do not exist in
practice. Here, a modified MIXnorm model was used to generate synthetic data sets (un-
der the same settings as in Simulation VI in Yin et al. [67]). The model parameters were
set to their MLEs estimated from a public RNA-seq dataset for FFPE soft tissue sarcomas
samples [30], which contains expression levels for 20, 242 protein-coding genes from 41
patients.
The sample size was set to a multiple of 41 from 41 to 2, 050. The average comput-
ing time for SMIXnorm and MIXnorm over 50 replicates is plotted against sample size
in Figure 2.4. Both SMIXnorm and MIXnorm show a linear relationship between the av-
erage computing time and the sample size with Pearson correlations greater than 0.99.
The linear regression fit of the SMIXnorm computing time against sample size results in
a slope estimate of 0.051, compared to 0.297 from MIXnorm. To evaluate the performance
of SMIXnorm and MIXnorm together with five commonly used FF RNA-seq normaliza-
tion methods (PS, UQ, DESeq, RPM and TMM), we calculated the gene-wise Pearson
correlations for the 20, 242 genes between the normalized and true expression for each
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of the 50 simulated data set under the setting of 41 samples. The results are reported in
Figure B.1 of Appendix B.2, showing that SMIXnorm and MIXnorm have almost identical
performance and they consistently beat the other methods.
2.3.2. Data application
When dealing with real data where true expression is unknown, researchers often
consider frozen sections as the gold standard for most molecular assays. As mentioned
in the introduction, the frozen process maintains RNA well, compared to the FFPE pro-
cess. Therefore, we used the paired FF RNA-seq expression after normalization as a
surrogate to the true gene expression in our three data examples, in order to evaluate the
performance of different normalization methods.
Colorectal cancer data. The colorectal cancer data [41] contains 54 selected FFPE
tumor specimens from a larger multi-center cohort with paired FF samples. Gene expres-
sion levels were measured by whole genome RNA-seq (RNA-Acc) assay and Affymetrix
GeneChip (Affy) platform on the FFPE samples and FF samples, respectively.
The activation of RAS signaling pathway is frequent in human cancer. Recent studies
have shown that RAS mutations account for approximately 40% of colorectal cancers and
lung cancers [41]. A number of RAS pathway activation gene expression signatures have
been identified using multiple types of cancer cell lines and human FF samples. Omolo et
al. [41] evaluated an 18-gene RAS pathway signature on FFPE samples in five technology
platforms. We focus on the Illumina whole genome RNA-seq of FFPE samples and the
gold standard FF samples measured by Affymetrix GeneChip. The Affy_FF samples were
normalized using the RMA method [25, 41].
To assess the performance of the translation of the gene signature from FF to FFPE
samples, we considered the same metric as in Omolo et al. [41]. The RAS pathway
activation score is defined as the mean normalized expression levels of the 18 RAS genes
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Figure 2.4: Simulation study. Average computing time of SMIXnorm and MIXnorm vs.
sample size
for each sample. We calculated the Spearman correlation using the 54 pairs of FF and
FFPE RAS pathway activation scores for each normalization method and summarized the
results in Table 2.1. The raw data give the lowest correlation as expected. SMIXnorm and
MIXnorm give almost the same results and the highest correlations. The p-value based on
a two-sided permutation test for the hypothesis H0 : ρ = 0 is reported in the parenthesis.
SMIXnorm, MIXnorm, PS, DESeq, RPM and UQ report significant correlations at the
significance level of 0.05. MIXnorm takes about 42 seconds to normalize the colorectal
cancer data, while SMIXnorm only takes about 7.5 seconds.
Table 2.1: Correlations ρ between normalized FF and FFPE RAS pathway activation
scores. p-values in the parenthesis are based on a two-sided permutation test for the
hypothesis H0 : ρ = 0.
SMIXnorm MIXnorm PS DESeq
ρ 0.343
(0.012)
0.343
(0.011)
0.324
(0.017)
0.298
(0.029)
RPM UQ TMM Raw
ρ 0.286
(0.036)
0.270
(0.049)
0.153
(0.269)
0.125
(0.366)
Soft tissue sarcomas data. The soft tissue sarcomas data [30] measure the ex-
pression levels of 20, 242 protein-coding genes from 41 patients with paired FF and FFPE
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samples. To evaluate the normalization performance, the gene-wise Pearson correlations
between normalized FFPE and FF expression levels (in the log scale) were computed
and compared among the seven different methods (SMIXnorm, MIXnorm, DESeq, RPM,
TMM, PS and UQ). A gene expression signature, Complexity INdex in SARComas (CIN-
SARC), which contains 67 genes, has been identified as an important prognostic factor
in sarcomas using fresh frozen samples. Lesluyes et al. [30] showed that CINSARC
remains a potential prognostic factor using the FFPE RNA-seq data. Therefore, we eval-
uated the performance of different normalization methods on all the 20, 242 genes as well
as the 67 genes in the CINSARC gene signature.
Figure 2.5 shows the gene-wise Pearson correlations for all the 20, 242 genes using
violin plots. The dot and line in each violin plot represent the mean and standard devia-
tion of the gene-wise Pearson correlations. The gene-wise correlations from the 67 genes
in the CINSARC signature are summarized in Table 2.2 using the first, second and third
quartiles. Note that UQ failed to normalize the data as the scaling factor estimates equal
0 for some samples due to the excess zero counts. The genes in the gene signature have
higher correlations than those calculated from the population of all protein-coding genes
for all the normalization methods. The shapes of the violin plots suggest that SMIXnorm
and MIXnorm have almost identical results and SMIXnorm gives the highest mean cor-
relation while PS gives the lowest among all the methods. The three commonly used
FF RNA-seq normalization methods, TMM, DESeq and RPM, give similar results on all
protein-coding genes and there is no clear improvement compared to the original correla-
tions calculated without any normalization. However, DESeq and RPM show much higher
correlations on the CINSARC gene signature compared to TMM. Overall, SMIXnorm and
MIXnorm show similar results and are consistently better than the other methods. We
further note that in this example, a poor choice of normalization method (e.g., UQ, TMM
or PS) may yield results worse than those from original unnormalized data. MIXnorm
takes about 5 minutes to normalize the soft tissue sarcomas data and we note that the
algorithm reaches the default maximum number of iterations before convergence. On the
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other hand, SMIXnorm converges in 6 iterations and takes about 10 seconds to normalize
the data.
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Figure 2.5: Gene-wise correlations between normalized FFPE and FF expression for
soft tissue sarcomas data on all 20, 242 protein coding genes. The UQ method failed to
normalize the data due to excess zero counts.
Clear cell renal cell carcinoma data. The clear cell renal cell carcinoma (ccRCC)
data are available in the repository Gene Expression Omnibus from a published study
[13]. ccRCC is the most common and aggressive histological type among the primary
renal neoplasms. Metastasis is a major cause of ccRCC patient death due to the resis-
tance to standard chemotherapy and radiotherapy. Hence, much effort has been made to
unravel the underlying molecular mechanisms of ccRCC, for example, by applying gene
expression analysis to develop molecular signatures of disease progression, which plays
an important role in assessing the carcinogenesis and development of disease as well
as guiding clinical decisions. The ccRCC RNA-seq data contain 32 pairs of FFPE and
RNAlater samples with 18, 458 protein-coding genes converted from 64, 253 Ensembl an-
notated genes. Following Yin et al. [67], the RNAlater samples were considered the gold
standard in this study and gene-wise Pearson correlations were computed to compare the
performance of the seven normalization methods. The results are shown via violin plots
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Table 2.2: Gene-wise correlations between normalized FFPE and FF expression for soft
tissue sarcomas data on the CINSARC gene signature. The UQ method failed to normal-
ize the data due to excess zero counts.
First Qu. Median Third Qu.
SMIXnorm 0.344 0.465 0.529
MIXnorm 0.333 0.455 0.517
DESeq 0.165 0.260 0.354
RPM 0.146 0.243 0.350
TMM 0.010 0.098 0.161
PS -0.126 0.002 0.154
UQ - - -
Original 0.020 0.107 0.181
in Figure 2.6. Again, we observe that SMIXnorm and MIXnorm give almost the same
results and consistently perform the best among all methods. It is interesting to note that
TMM, which performs the best among existing FF normalization methods in soft tissue
sarcomas data on all protein-coding genes, gives worse results than DESeq, RPM and
UQ in this application. In fact, TMM and PS show no advantage compared to the original
correlations without any normalization. MIXnorm takes about 10.5 seconds to normalize
the ccRCC FFPE data, while SMIXnorm only takes about 3.3 seconds.
2.4. Discussions
We have developed an efficient normalization method, named SMIXnorm, for FFPE
RNA-seq data normalization. Modified from the MIXnorm statistical model, we use a sim-
ilar two-component mixture model to separately model the expressed and non-expressed
genes. The simplifications of the statistical model avoid the complex likelihood function
and the need of a complicated latent variable structure to invoke the nested EM algorithm.
We have shown through real data applications and simulation studies that SMIXnorm
greatly reduces the complexity of the likelihood function and the computing time without
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Figure 2.6: Gene-wise correlations between normalized FFPE and RNAlater for ccRCC
data on 18, 458 protein coding genes.
sacrificing the performance. Though other FF normalization methods take only about 1
second to normalize each dataset in our three data applications, their performance is not
comparable to that of SMIXnorm and MIXnorm for FFPE samples. Some FF normaliza-
tion methods perform even worse than the use of original data without any normalization.
We mentioned in the soft tissue sarcomas application that MIXnorm failed to con-
verge at the default maximum number of iterations and tolerance level. Due to the
severely different RNA degradation levels among the 41 soft tissue sarcomas FFPE sam-
ples, 10 FFPE samples have more than 10, 000 zero counts and 9 FFPE samples have
less than 3, 000 zero counts. Consequently, MIXnorm gives negative estimated sample-
specific location parameters of the truncated normal distributions for those samples with
a higher proportion of zero counts, which blurs the distinction between expressed and
non-expressed genes. SMIXnorm models the expressed genes by normal distributions
without truncation, which naturally constrains the location parameters to be non-negative
in all the EM iterations as sample means are used for estimation. Thus, SMIXnorm seems
to be more robust and converges faster than MIXnorm.
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Recently, single-cell RNA sequencing (scRNA-seq) becomes an important technology
in molecular analysis. While bulk RNA-seq measures the expression in the population
level across cells, scRNA-seq allows for the cell level resolution and therefore, reveals
heterogeneity of cell subpopulations. Similar to FFPE RNA-seq data, a prominent feature
of scRNA-seq data is the sparsity. The high proportion of zero count arises for both
biological reasons and technical reasons [35, 60]. The most commonly used scRNA-seq
normalization method is SCnorm [2], which uses quantile regression to group genes by
estimated count-depth relationships, and then estimates different scaling factors within
each group via a second quantile regression. Other popular scRNA-seq normalization
methods, including BASiCS [58], SAMstrt [26] and GRM [60], rely on spike-ins. Therefore,
most scRNA-seq normalization methods are not directly applicable to the FFPE RNA-seq
data that typically do not have spike-ins.
With the rapid adaption of FFPE samples in RNA-seq analysis, it is important for users
to realize that different normalization procedures should be used for FFPE vs. FF data.
We offer RSeqNorm, a comprehensive and user-friendly normalization toolkit for RNA-
seq data. To the best of our knowledge, RSeqNorm is the only available web-based tool
that integrates different normalization methods for both FFPE and FF RNA-seq data. It
includes seven normalization methods, among which five are commonly used (RPM, UQ,
DESeq, TMM and PS) for FF or like RNA-seq data. Though MIXnorm and SMIXnorm are
specifically designed for FFPE RNA-seq normalization, they can be applied to FF data
directly. However, it is generally inappropriate to implement other existing methods on
FFPE data. The input for all methods is a read count matrix at the gene level. The output is
an expression matrix after normalization with the same dimension as the input data. The
R package, RSEQNORM, which implements SMIXnorm and MIXnorm is downloadable
from the website (http://lce.biohpc.swmed.edu/rseqnorm).
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CHAPTER 3
SHEAP: Detecting Spatially Expressed Genes via a Bayesian Spatial Heaping Model for
3.1. Introduction
RNA sequencing (RNA-seq) and single-cell RNA sequencing (scRNA-seq) have been
essential technologies to study organism development, normal and cancer tissues in
biomedical research [10]. One key step in most molecular profiling technologies is tis-
sue dissociation. Tissue dissociation is the process of using enzymes to digest tissue
pieces and release cells from the tissue to the best possible quality for further sequencing
experiments [10, 36]. However, this dissociation process leads to a loss of tissue morpho-
logical and spatial information. As a consequence, the association between sequencing
data and tissue morphology has been overlooked for a long time. In order to explore such
association, much effort has been devoted to combine molecular profiling experiments
and imaging experiments. Recent advances in spatial molecular profiling technologies
have enabled a comprehensive catalog of cell spatial organizations and their mRNA.
Spatial molecular profiling technologies are mainly of two branches: imaging-based
and sequencing-based. The imaging-based technologies, including single-molecule fluo-
rescence in situ hybridization (smFISH) [16, 46], seqFISH [14, 34] and multiplexed error-
robust FISH (MERFISH) [7], first hybridize RNAs with fluorescent probes in situ. Then the
fluorescent sequences are quantified by mass spectrometry or microscopy. Sequencing-
based technologies, such as spatial transcriptomics technology (ST) [53], high-definition
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Zero-Inflated Spatial Transcriptomics Data
spatial transcriptomics (HDST) [62] and slide-seq [50], incorporate additional spatial bar-
code in the sample preparation phase to trace back the original location of molecules.
Then the expression and spatial information is obtained by complementary DNA (cDNA)
sequencing. Though the two branches of technologies have different features, studies
have shown that both are able to extract expression and spatial information of sufficient
quality from varies types of tissues [68].
Traditional profiling data analysis mainly focuses on comparison of gene expression
levels between groups of samples with different phenotypes, that is, identifying differ-
ently expressed (DE) genes. In the context of spatial profiling, however, a new question
of interest is to study the association between gene expression levels and their spatial
locations, i.e., identifying spatially expressed (SE) genes. Figure 3.1 illustrates an SE
gene vs. a non-SE gene in spatially resolved expression profiles of a mouse olfactory
bulb tissue [53], where a lighter color indicates higher expression. Edsgärd et al. [12]
proposed Trendsceek, which detects SE genes by a permutation test. Specifically, each
gene is tested independently, and four summary statistics (Stoyan’s mark-correlation ρ,
mean-mark function E, variance-mark V , and mark-variogram γ) are calculated to cap-
ture different aspects of the spatial distribution. Reference distributions of these statistics
are then obtained from random permutations of gene expression levels at different lo-
cations. Finally, for each summary statistic, the p-value for detecting an SE gene can
be computed as the probability of observing the statistic as extreme or more extreme
than its observed value using the corresponding reference distribution. Note that the four
statistics may have different power depending on the actual spatial distribution under con-
sideration. SpatialDE [55] and SPARK [54] are both model-based methods that employ
Gaussian processes to characterize spatial dependency. SpatialDE models the log trans-
formed expression profiles for a given gene across spatial locations by a multivariate nor-
mal distribution, whose covariance matrix can be decomposed into a covariance matrix
of a Gaussian process incorporating spatial correlations and an independent non-spatial
variation in gene expression. Testing SE genes is equivalent to a likelihood ratio test with
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an asymptotic χ2 approximation, which compares the model with and without the spatial
correlations. SPARK models the raw count data by Poisson distributions with mean rates
across spatial locations depending on a Gaussian Process. Benchmark comparisons by
Sun et al. [54] and Zhang et al. [68] suggest that SPARK gives the best performance
in most situations, followed by SpatialDE. Trendsceek has less power in identifying SE
genes, and also requires intensive computation.
(A) SE gene (B) non−SE gene
Figure 3.1: Spatially resolved expression profiles. (A) example of spatially expressed (SE)
gene. (B) example of non-spatially expressed gene.
Gene expression data from spatial profiling are characterized by conspicuous zero
inflation due to either technical issues, such as a limited sequencing depth or fluorescent
level, or biological issues that some genes are indeed silent in a particular condition.
For example, the mouse olfactory bulb data and breast cancer data [53–55] analyzed
by both SpatialDE and SPARK contain about 60% and 90% zero counts, respectively.
Nevertheless, none of the existing methods address the zero inflation issue formally. We
propose a Bayesian Spatial HEAPing model (SHEAP), which aims to accurately recover
major spatial patterns underlying the gene expression levels that are partially observed
and subject to heaping at zero.
Heaping is a special case of coarse data [24] and arises naturally in many applications,
especially those with self-reported data. For example, if age is recorded in months, peo-
ple may report ages rounded to the nearest year (full-year heaper) or half-year (half-year
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heaper) or the nearest month (exact reporter), and a reported age of 24 months can be
due to full-year heaping, half-year heaping as well as an exact report. Heitjan and Rubin
[23] modeled these heaping behaviors and studied the effect of age heaping on inference
about the nutritional status of Tanzanian children. Other authors such as Pickering [43]
and Wright and Bray [66] also modeled data with certain heaping mechanisms to improve
statistical inference in medical studies. In the context of spatial profiling, gene expres-
sion count data with excess zeros can be treated as a special case of heaped data. An
observed zero count may arise from either a truly non-expressed gene or an expressed
gene, but the experiment fails to detect its expression because of various technical issues.
Further, a zero count, due to a limited sequencing depth or fluorescent level, is more likely
to occur among lowly expressed genes.
Among methods developed for detecting SE genes, our proposed method makes the
first attempt to accurately model the heaping mechanism underlying zero-inflated count
data. SHEAP also extends the existing heaping models to account for spatially correlated
count data, which also allows the probability of heaping to be spatially dependent. Further,
a hurdle model is employed to incorporate model selection seamlessly into the Bayesian
framework for detecting SE genes. Through elaborate Bayesian hierarchical modeling
that accounts for heaping, spatial dependency, and SE testing under one nutshell, SHEAP
is powerful in detecting SE genes and uncovering spatial patterns, as will be confirmed
by our numerical results.
The paper is structured as follows. In Section 3.2, a heaping data model is proposed
to model the observed count data and multi-layer Bayesian hierarchical structures are in-
troduced to model the heaping mechanism and the latent spatial process; Bayesian com-
putation and inference is further elaborated on the proposed hierarchical model. Section
3.3 evaluates the performance of the proposed method by simulation studies and two data
applications in mouse olfactory bulb data and breast cancer data. Concluding comments
and future research directions are briefly outlined in Section 3.4.
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3.2. Methods
Let the integer-valued matrix Y denote the gene expression data measured on I lo-
cations and J genes from a spatially resolved transcriptomic study. Each element Yij
denotes the raw read count of gene j from location i, for i = 1, ..., I and j = 1, ..., J . Fur-
ther, let T be an I × 2 matrix with the i-th row (ti1, ti2) denoting the coordinates of location
i in a two-dimensional Euclidean space.
3.2.1. A spatial heaping model for count data
Consider modeling one gene at a time and so we ignore the subscript of the gene.
Let Yi denote the observed gene expression at location i for i = 1, ..., I. Let Zi be a
latent variable denoting the underlying expression at location i, and Zi|λi ∼ Poi(siλi)
where si is the size factor of location i reflecting systematic biases that affect measured
gene expression levels and λi denotes the normalized expression level from location i.
To ensure identifiability of these two sets of parameters, we use a plug-in estimate for
s = (s1, ..., sI) [54], where each si is estimated by the total sum of counts at location i and
subject to the constraint
∏I
i=1 si = 1. Next, define a latent binary variable Gi to indicate
whether Zi can be directly observed or heaped on zero such that the observed expression
Yi is a function of Zi and Gi, namely
Yi = Y (Zi, Gi) =

Zi
0
if Gi = 1,
if Gi = 0.
An observed nonzero expression Yi = y indicates that the corresponding (Zi, Gi) = (y, 1)
for y 6= 0. However, any observed zero expression may arise from more than one possible
(z, g) pairs; that is, g can be either zero or one: if g = 0, then z can be any count from
the Poisson distribution; if g = 1, then z must equal zero. For each possible y value, we
denote the set of such pairs as ZG(y) = {(z, g) : y = Y (z, g)} so that
48
p(Yi = y|gi, zi) =

1
0
if (zi, gi) ∈ ZG(y),
otherwise.
Further, we assume that Gi|Zi∼ Ber(φi), where logit(φi) = β0 + β1Zi. This is because
lowly expressed genes are more likely to have their expression heaped on 0 due to the
low amounts of mRNA and insufficient mRNA capture, and can be approximately captured
by the linear relationship in the logit scale.Thus, the marginal probability of Yi = y, given
parameters λi, β0, and β1, can be written into
p(Yi = y|λi, β0, β1) =
∑
ZG(y)
p(y|gi, zi)p(gi|zi, β0, β1)p(zi|λi),
which, combined with a logistic regression model for Gi, can be further written as
p(Yi = yi|λi, β0, β1)
= I(yi = 0)
∞∑
z=0
p(g = 0|z, β0, β1)p(z|λi) + p(g = 1|z = yi, β0, β1)p(z = yi|λi)
= I(yi = 0)
∞∑
z=0
1
1 + exp(β0 + β1z)
p(z|λi) +
exp(β0 + β1yi)
1 + exp(β0 + β1yi)
p(z = yi|λi),
where I(·) is the indicator function.
Similarly as in [23, 64], the above model contains three main elements: the underly-
ing expression levels Z at the sample locations and their distributions; the zero inflation
mechanism G given Z via a classical logistic regression setup; and a mapping from
(Z,G) to the observed heaped counts Y , where Z ≡ (Zi)Ii=1, and G and Y are defined
similarly. Note that Heitjan and Rubin [23] assumed independence across sampling units
given parameters. We generalize the heaping model by incorporating potential spatial
dependence into both Z andG by modeling the (log) mean structure of Z via a Gaussian
Process, namely
log(λ) ∼ MVN(µ, σ2K(l)), (3.1)
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where λ ≡ (λi)Ii=1, and µ = 1 · µ (i.e., all locations have a common mean µ). The corre-
lation matrix K(l) (we write K(l) = K thereafter) incorporates potential spatial patterns
through a kernel function such as the squared exponential kernel, the Cauchy kernel or
the Ornstein-Uhlenbeck kernel, and l is the characteristic length parameter. For example,
a squared exponential kernel, used in our numerical examples in Section 3.3, gives the
(i, j) elementKij = exp(− d
2
ii
2l2
) for i 6= j, andKii = 1, where dij =
√
(ti1 − tj1)2 + (ti2 − tj2)2
is the Euclidean distance between locations i and j. We denote the above model by M1.
A reduced case of M1 is the model assuming that K is an identity matrix (i.e., l = 0),
denoted M0, corresponding to a non-SE gene.
3.2.2. Prior specification
We specify the following prior distributions for the parameters µ and σ2 introduced by
the Gaussian Process (3.1),
µ|σ2 ∼ N(µ0, hσ2), σ2 ∼ Inv-Gamma(aσ, bσ),
where h = 10, aσ = 3, bσ = 10, and µ0 is set to the mean of log(Yi)’s for Yi > 0. Note that h
is set to a number larger than 3 so that where the center µ0 is located is not so important
and thus we use a rough estimate here. We specify a bivariate normal prior for the logistic
regression parameters β = (β0, β1)T ,
β ∼ N(b,B),
where b = (0, 0)Tand B = 100 · I indicate a diffuse and vague prior. We further use a
hurdle model to specify the prior distribution for l, which introduces a binary latent variable
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D for model selection between M0 and M1,
l|D ∼

I(l = 0) D = 0,
U[Ll, Ul] D = 1,
D ∼ Bern(0.5). (3.2)
For the case of D = 0, l = 0 with probability 1 so that K reduces to an identity matrix,
which corresponds to the null model M0. The hurdle is cleared if D = 1 with a prior
probability of 0.5. Therefore, (3.2) assumes that M1 and M0 are equally likely a priori.
Note that the value of the lower bound Ll determines the minimum detectable spatial
correlation. We set Ll to half of the 1-percentile of all pairwise Euclidean distances dij ’s,
which leads to the top 1% pair-wise correlation in K greater than exp(−2) ≈ 0.135. We
also note that the inverse of K becomes numerically unstable as l increases, due to
the singularity of the resulting covariance matrix. Thus, we set Ul to the median of the
pairwise Euclidean distances in our algorithm implementation.
3.2.3. Posterior computation and inference
Figure 3.2 shows the hierarchical structure of the proposed SHEAP model via a di-
agram. The conjugate N-Inv-Gamma prior setting for µ and σ2 that takes the form of
p(µ, σ2) = p(µ|σ2)p(σ2) allows us to integrate the Gaussian Process mean and the co-
variance scaling factor out of p(logλ|µ, σ2, l), yielding a generalized multivariate Student’s
t-distribution on logλ:
p(logλ|l) ∝|K|−
1
2H−
1
2{
bσ +
1
2
[
logλTK−1 logλ− 1
H
(1TK−1 logλ− µ0
h
)T (1TK−1 logλ− µ0
h
)
]}−aσ− I2
,
where H = K−1·· +
1
h
, K−1·· is the grand sum of the matrix K−1; 1 is an I × 1 vector of 1;
µ0, h, aσ and bσ are pre-specified hyper-parameters as mentioned in Section 3.2.2.
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Figure 3.2: The hierarchical structure of the SHEAP model.
Let Θ = (l, β0, β1). The full probability model, after marginalization over µ and σ2, is
given by
p(Y ,G,Z, logλ,Θ) = p(Y |G,Z,Θ)p(G|Z,Θ)p(Z|λ,Θ)p(logλ|Θ)p(Θ|D)p(D)
=
I∏
i=1
{
I[(zi, gi) ∈ ZG(yi)]
[exp(β0 + β1zi)]
gi
1 + exp(β0 + β1zi)
(siλi)
zi
zi!
exp(−siλi)
}
p(logλ|l)p(Θ|D)p(D).
To employ a Gibbs sampler for posterior computation using Markov chain Monte Carlo
(MCMC), we first derive the complete set of full conditionals. First note that

p(Gi = 1|Yi > 0) = 1,
p(Gi = 0|Yi = 0, Zi > 0) = 1,
p(Gi = 0|Yi = 0, Zi = 0, β0) = 11+eβ0 ,
p(Gi = 1|Yi = 0, Zi = 0, β0) = e
β0
1+eβ0
.
Thus, in each MCMC iteration, we set Gi ≡ 1 if Yi > 0, and set Gi = 0 if Yi = 0 and Zi > 0;
we update each Gi sequentially only if Yi = Zi = 0 by sampling from a Bernoulli(φ)
distribution with φ = 1
1+eβ0
, where Zi and β0 take values from the most recent updates.
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The full conditionals for λ and Z are given by

p(Zi = Yi|Gi = 1) = 1,
p(Zi = z|Gi = 0, λi, β0, β1) ∝ (siλi)
z
(1+eβ0+β1z)z!
for z≥0,
(3.3)
p(log λi|Zi, l, logλ−i) ∝ (siλi)Zie−siλi
{
bσ +
1
2
[
logλT
(
K−1 −HK−1JK−1
)
logλT
]}−aσ− I2
,
where λ−i = (λ1, ..., λi−1, λi+1, ..., λI). Since these are not known distributions and cannot
be sampled directly, we use the Metropolis-Hastings algorithm to sample λ and Z [22].
See Appendix C.1 for the detail.
The Polya-Gamma method [44] is employed to sample from the full conditional dis-
tribution of β efficiently. We first sample a latent variable conditional on β and Z by
ωi|β, Zi ∼ Polya-Gamma(1,β0 + β1Zi). Then sample the full conditional of β by
β|Z,G,ω ∼ N(mω, Vω),
where Vω = (ZT1 ΩZ1 +B−1)−1 and mω = Vω(ZT1 κ +B−1b), where Z1 is an I × 2 matrix
with its first column being 1’s and second column being Z ′is, κ = (g1 − 12 , . . . , gI −
1
2
), and
Ω is the diagonal matrix of ωi’s.
Since l depends on D, we perform a joint update of the two parameters within each
Gibbs sampling iteration using another M-H step. To do so, we first propose D∗ = 1−D.
If D∗ = 1, we should propose l∗ from U [Ll, Ul]. Otherwise, we set l∗ = 0. The proposed
move is accepted with probability min(1,mD), where the hastings ratio mD is
mD =
p(logλ|l∗)p(D∗)p(l∗|D∗)J(D|D∗)J(l|l∗)
p(logλ|l)p(D)p(l|D)J(D∗|D)J(l∗|l)
,
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where p(D
∗)
p(D)
= J(D|D
∗)
J(D∗|D) = 1 and
p(l∗|D∗)J(l|l∗)
p(l|D)J(l∗|l) = 1. To further speed up the MCMC algorithm,
we replace the continuous uniform component in the prior distribution of l by a discrete
uniform distribution on T values (say T = 10). Specifically, we choose T equally-spaced
points from logLl to logUl. Then transform the points to the original scale by taking anti-
log to form the discrete uniform distribution.
Finally, to detect spatially expressed (SE) genes, we calculate p0 as the proportion of
l = 0 from its posterior samples after a burn-in period. A gene is identified as an SE gene
at the significance level of α if p0 < α.
3.3. Results
3.3.1. Simulation
We conduct simulation studies to evaluate and compare the performance of the pro-
posed SHEAP method and existing methods including SPARK, SpatialDE, and Trend-
sceek. The spatial heaping model specified in Section 3.2.1 is considered as the data
generating model in our simulation study I, and we control the zero-inflation proportion by
varying the value of β0. Specifically, we generate 100 random location coordinates by a
two-dimensional uniform distribution on [5, 25] × [5, 25], which is approximately the range
of coordinates from a published spatial profiling data [53]. We set µ = 2.5, β1 = 0.12 and
β0 = −1.5,−2.5,−3.5 to reflect low, median and high levels of zero inflation. The 3 settings
of β0 correspond to approximately 45%, 60% and 75% of zeros within each gene. We also
consider a no-extra zero setting that corresponds to a data generating model with G ≡ 1
(i.e., heaping on zero does not occur). The size factor s = (s1, ..., sI) is generated from
a N(1, 0.2) distribution on each location independently. For SE genes, we set the scal-
ing parameter σ2 = 1 in the Gaussian Process covariance matrix and the characteristic
length parameter l to the 5-percentile of all pair-wise Euclidean distances. For genes with
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no spatial pattern, we simply set σ2K to an identity matrix. Ten SE genes and ten non-SE
genes are generated in each of the four settings for different levels of zero inflation.
To detect SE genes, we first obtain the p-values from each method. Then we con-
trol for false discovery rate (FDR) at the level of 0.05 using the Benjamini-Hochberg (BH)
procedure [3]. The results are shown in Table 3.1. All methods are able to control the
false discovery rate (FDR) well in the four settings considered. As mentioned in the in-
troduction, Trendsceek has four different versions, each using a different summary statis-
tic, including Stoyan’s mark-correlation ρ, mean-mark function E, variance-mark V , and
mark-variogram γ, Among them, the Stoyan’s mark-correlation ρ appears to be the best.
Nevertheless, all the four Trendsceek variants perform poorly, yielding no/low power, re-
gardless of the level of zero inflation. The other methods perform well in the no-extra
zero setting: the proposed SHEAP and SpatialDE detect all the SE genes,and SPARK
detects 9 out of the 10 SE genes. As the degree of zero inflation increases from low to
high, SHEAP retains great performance by identifying all the SE genes meanwhile main-
taining the zero FDR. SpatialDE has an increasing power as the proportion of extra zeros
increases, and so it is better than SPARK whose power is steadily low.
Figure 3.3 shows receiver operating characteristic (ROC) curves based on false dis-
covery rates under each of the four settings. In the high proportion of extra zeros setting,
all methods tend to have a high area under the ROC curve (AUC). We note that for SE
genes, the heaping phenomenon amplifies the spatial correlations among lowly expressed
locations, since heaped zero expressions help make (nearly) perfect correlations. In ad-
dition, the zero inflation causes over-dispersion on the count data. SpatialDE models the
log-transformed expression directly by a Gaussian Process, which has an additional pa-
rameter to model the variance. However, SPARK models the count data by a Poisson
distribution, which is known to be inadequate for over-dispersed data. Overall, SHEAP is
the only method that models the zero inflation rigorously and thus has consistently good
performance regardless of the zero-inflation level.
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Extra zeros Zero Low Median High
TP FP AUC TP FP AUC TP FP AUC TP FP AUC
SHEAP 10 0 1 10 0 1 10 0 1 10 0 1
SPARK 9 0 1 3 0 0.98 4 0 0.95 3 0 1
SpatialDE 10 0 1 3 0 0.96 7 0 0.935 9 0 0.99
Trendsceek.E 0 0 0.75 0 0 0.34 0 0 0.435 0 0 0.67
Trendsceek.ρ 3 1 0.83 0 0 0.77 3 1 0.81 3 1 0.84
Trendsceek.γ 0 0 1 0 0 0.91 0 0 0.80 4 0 1
Trendsceek.V 0 0 0.67 0 0 0.70 0 0 0.615 0 0 0.70
Table 3.1: True positive (TP), false positive (FP) and area under the ROC curve (AUC)
results for Simulation I. Ten spatially expressed genes and ten non-spatially expressed
genes are generated in each setting. Zero, low, median and high proportion of extra
zeros correspond to approximately 45%, 60% and 75% of zeros within each gene. TP (FP)
is the number of correctly (falsely) identified SE genes.
In Simulation II, we exam the performance of the methods under different levels of
spatial correlations. We set l to the 2.5- and 10-percentile of all pair-wise Euclidean dis-
tances to reflect low and high levels of spatial correlations. All other parameters are set to
the same values as in simulation I, and we fix β0 at −2.5, which produces approximately
60% zeros within each gene to mimic the real scenario [53]. Again, ten SE genes and ten
non-SE genes are generated in each of the two settings.
Table 3.2 summarizes the results from simulation II. SHEAP is able to identify almost
all SE genes and makes no false positives in both settings. The second best method,
SpatialDE, detects only one SE gene in the low spatial correlation setting and seven in
the high spatial correlation setting. SPARK and Trendsceek.ρ show no power in detecting
SE genes in the low correlation setting, and detect about half of the SE genes in the
high correlation setting. Trendsceek.E, Trendsceek.γ and Trendsceek.V have no power in
either setting. The ROC curves based on false discovery rates are reported in Figure 3.4.
Clearly, the proposed SHEAP offers the best performance with the AUC equal to one in
both settings.
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Spatial correlation Low High
TP FP AUC TP FP AUC
SHEAP 9 0 1 10 0 1
SPARK 0 0 0.3 5 0 0.95
SpatialDE 1 0 0.79 7 0 0.96
Trendsceek.E 0 0 0.63 0 0 0.53
Trendsceek.ρ 0 0 0.68 4 1 0.74
Trendsceek.γ 0 0 0.46 0 0 0.82
Trendsceek.V 0 0 0.57 0 0 0.51
Table 3.2: True positive (TP) and false positive (FP) results for Simulation II. Ten spatially
expressed genes and ten non-spatially expressed genes are generated in each setting.
l is set to 2.5- and 10-percentile of all pair-wise Euclidean distances in the low and high
spatial correlation setting, respectively.
3.3.2. Data application
We apply the proposed SHEAP method to analyze two published datasets and com-
pare its performance with the existing methods SpatialDE, SPARK, and Trendscreek.
Mouse olfactory bulb data. The mouse olfactory bulb data [53] contains 11, 274
genes measured on 260 locations by spatial transcriptomics sequencing. In the origi-
nal study, Ståhl et al. [53] presented a list of 10 marker genes in the olfactory system.
These genes are known to have enriched expression in the mitral cell layer (MCL) but low
expression or even no expression in the adjacent granular cell layer (GCL), and so they
should exhibit spatial patterns. The proposed SHEAP detects 9 of the 10 marker genes as
SE genes (Figure 3.5) and SPARK detects 8, SpatialDE detects 3 and all the four statistic
tests of Trendsceek detect none of them. We summarize the 95% credible interval of l in
Table 3.3.
It is worth noting that SPARK performs almost as good as the proposed SHEAP. We
further examined the data and found that these 10 genes have only 3.4% zeros on average,
while the whole mouse olfactory bulb dataset contains 59.6% zeros.
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Doc2g Uchl1 Nmb Plcxd2 Shisa3 Sv2b Cdhr1 Reln Slc17a7 Rcan2
LL 0.82 0 0.51 0.65 0.65 0.51 0.65 0.65 0.65 0.51
UL 0.82 0.51 0.82 0.82 0.82 0.65 0.65 0.65 0.65 0.65
p0 0 0.71 0 0 0 0 0 0 0 0
Table 3.3: Mouse olfactory bulb data. Analysis of the 10 marker genes in mouse olfactory
bulb data. LL and UL are the lower and upper limits of the 95% credible interval of l. p0 is
the proportion of l = 0 from its posterior samples after burn-in.
Breast cancer data. We consider a human breast cancer dataset [53] in our sec-
ond data application. The data consist of spatial transcriptomics of human breast cancer
biopsies measured on 5, 262 genes and 250 locations. Ståhl et al. [53] identified, on the
basis of morphological criteria, one area with invasive ductal cancer and six separate ar-
eas of ductal cancer in situ. In the original study, 14 extracellular matrix-associated genes
showed high expression in the invasive ductal cancer area. In addition, their expression
levels in the ductal cancer in situ areas suggested a high degree of heterogeneity. We
summarize the results of extracellular matrix-associated genes in Table 3.4. SHEAP iden-
tifies all the 14 extracellular matrix-associated genes as spatially expressed genes (Figure
3.6), whereas SPARK detects only 10, SpatialDE detects 7, and Trendsceek detects only
2 (false discovery rate < 0.05 for at least one of the four statistic tests). Further, seven
of the extracellular matrix-associated genes are highly zero-inflated with the zero propor-
tion greater than 67%. SHEAP and SpatialDE are able to detect all of the 7 genes while
SPARK detects 3. For example, GAS6, which is related to the epithelial-to-mesenchymal
transition [17, 18], was detected by SHEAP and SpatialDE only. The expression of GAS6
is high only in two of the ductal cancer in situ area, which may reflect different subclones.
3.4. Discussion
We have developed a new Bayesian method, SHEAP, for identifying SE genes in spa-
tial transcriptomics studies. SHEAP is based on the assumption that the observed ex-
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POSTN MMP14 SPARC IGFBP5 DCN SCGB2A2 FN1
LL 0.81 0.51 0.64 0.81 0.64 0.51 0.81
UL 0.81 0.64 0.81 0.81 0.81 0.81 0.81
p0 0 0.0005 0 0 0 0.0005 0
VIM GAS6 KRT17 AREG PEG10 MUCL1 PIP
LL 0.64 0.64 0.64 0.81 0.51 0.51 0.51
UL 0.81 0.81 0.81 0.81 0.81 0.81 0.81
p0 0 0 0 0 0 0.0005 0.0075
Table 3.4: Breast cancer data. Analysis of the 14 extracellular matrix-associated genes.
LL and UL are the lower and upper limit of the 95% credible interval of l. p0 is the proportion
of l = 0 from its posterior samples after burn-in.
pression level is a function of an underlying expression level, which incorporates potential
spatial patterns and is subject to heaping at zero. By modeling the heaping behavior,
whose distribution depends on the underlying expression level, we rigorously model the
zero inflation issue that is often observed in spatial transcriptomics data. An efficient
MCMC algorithm is designed for valid bayesian inference. Simulation studies and real
data applications show that the proposed SHEAP is more powerful than the existing com-
petitors, especially in situations of a high proportion of excess zeros.
A common approach to characterize the excess zeros in sequencing data is using a
zero-inflated distribution [8, 69]. A zero-inflated distribution accounts for the proportion
of extra zeros by a single parameter, and the presence of an extra zero is random in the
sense that it is not related to the potentially unobserved expression count. In practice,
however, the zero count, due to a limited sequencing depth, is more likely to present
among lowly expressed genes. To the best of our knowledge, the proposed SHEAP is
the only method that accounts for this dependence between the underlying count and the
probability of observing an extra zero.
In our numerical experiments and data applications, we restrict our attention to the
squared exponential covariance kernel when modeling the spatial dependency. However,
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our method can be directly applied to other popular kernel functions such as the Cauchy
kernel and the Ornstein-Uhlenbeck kernel. Our Bayesian framework has the capacity
of further incorporating kernel selection and model averaging into the proposed SHEAP
method, which is an interesting future research direction.
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Figure 3.3: ROC curves at the false discovery rates from 0 to 1 for Simulation I. (A) no
extra zeros. (B) low proportion of extra zeros. (C) median proportion of extra zeros. (D)
high proportion of extra zeros.
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Figure 3.4: ROC curves at the false discovery rates from 0 to 1 for Simulation II. (A) low
spatial correlations. (B) high spatial correlations.
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Figure 3.5: Mouse olfactory bulb data. Spatial expression patterns for 9 SE genes iden-
tified by SHEAP. Expression levels are in the natural log scale. These genes are known
to have enriched expression in the mitral cell layer (MCL) but low expression or even no
expression in the adjacent granular cell layer (GCL).
63
5
10
15
20
25
10 15 20 25 30
x
y
POSTN
5
10
15
20
25
10 15 20 25 30
x
y
MMP14
5
10
15
20
25
10 15 20 25 30
x
y
SPARC
5
10
15
20
25
10 15 20 25 30
x
y
IGFBP5
5
10
15
20
25
10 15 20 25 30
x
y
DCN
5
10
15
20
25
10 15 20 25 30
x
y
SCGB2A2
5
10
15
20
25
10 15 20 25 30
x
y
FN1
5
10
15
20
25
10 15 20 25 30
x
y
VIM
5
10
15
20
25
10 15 20 25 30
x
y
GAS6
5
10
15
20
25
10 15 20 25 30
x
y
KRT17
5
10
15
20
25
10 15 20 25 30
x
y
AREG
5
10
15
20
25
10 15 20 25 30
x
y
PEG10
5
10
15
20
25
10 15 20 25 30
x
y
MUCL1
5
10
15
20
25
10 15 20 25 30
x
y
PIP
0 1 2 3 4
Figure 3.6: Breast cancer data. Spatial expression patterns for 14 SE genes identified
by SHEAP. Expression levels are in the natural log scale. These 14 extracellular matrix-
associated genes are cancer relevant and characterized as spatially expressed genes in
the original study [53].
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APPENDIX A
APPENDIX of CHAPTER 1
A.1. Approximating a discrete distribution by a continuous distribution
For a specific gene and sample, let C denote the raw count and L ≡ log(C + 1) is the
natural logarithm transformed count. Here, we drop the subscripts i and j for simplicity.
We note that L is a discrete random variable with support {0, log(1), log(2), ...}, but in
Section 3 of the main paper, a continuous distribution (i.e., a truncated normal distribution)
is used to approximate the discrete distribution of L for expressed genes (when D = 1).
Below is a justification for the validity of this approximation.
Let Θ denote the set of all parameters, we have
p(C|Θ) = p(C|D = 1,Θ)p(D = 1|Θ) + p(C|D = 0,Θ)p(D = 0|Θ),
where p(C|D = 0,Θ) is the probability mass function (PMF) of the ZIP distribution and
p(C|D = 1,Θ) is the PMF of some discrete distribution, both with support {0, 1, 2, ...}.
Suppose a random variable X ∼ TN(µ, σ2, 0,∞) is used to approximate L and fX
is the probability density function (PDF) of X. Let Y = g(X) ≡ exp(X) − 1 so that
X = g−1(Y ) = log(Y + 1). According to the change-of-variable theorem (i.e., Theorem
2.1.5 in Casella and Berger [5]), Y has a PDF given by fY = fX · (g−1)′ = fX · 1y+1 . Clearly,
Y is a continuous random variable on [0,∞). We now use Y to approximate C, namely
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P (C = c) ≈ P (c− 0.5 ≤ Y < c+ 0.5)
=
∫ c+0.5
c−0.5
fY dy
≈ 1
2
[fY (c− 0.5) + fY (c+ 0.5)] [c+ 0.5− (c− 0.5)]
≈ fY (c),
where the third line uses the area of a trapezoid to approximate the integral. Therefore,
the PMF of the discrete random variable C can be approximated by the PDF of Y directly.
The above approximation works well for expressed genes, whose observed counts are
not close to zero.
A.2. Technical Details of the Nested EM Algorithm
Let t denote the current iteration of the outer EM and k denote the current cycle of the
inner EM; letK denote the total number of cycles in the inner EM; let Θ denote the set of all
parameters. Given
∑J
j=1 Dj positive observations, the number of negative observations
from N(µi, σ2i ), denoted by Ti, is modeled by a negative binomial (NB) distribution,
Ti |D,Θ(t+
k−1
K
) ∼ NB
(
J∑
j=1
Dj,Φ
(
−µ
(t+ k−1
K
)
i
σ
(t+ k−1
K
)
i
))
,
where Φ (·) is the cumulative distribution function (CDF) of the standard normal distribution
N(0, 1). For j = J + 1, ..., J + Ti,
Lij | Yobs,Θ(t+
k−1
K
) ∼ TN
(
µ
(t+ k−1
K
)
i , σ
(t+ k−1
K
)
i ,−∞, 0
)
.
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Let tk = t+ k−1K . Then the conditional expectations of the sufficient statistics are
s
(tk)
i = E
(
si | C,w(t),Θ(tk)
)
=
J∑
j=1
w
(t)
j Lij + T
(tk)
i m
(tk)
i ,
S
(tk)
i = E
(
Si | C,w(t),Θ(tk)
)
=
J∑
j=1
w
(t)
j L
2
ij + T
(tk)
i M
(tk)
i ,
where
T
(tk)
i = E
(
Ti | w(t),Θ(tk)
)
=
∑J
j=1w
(t)
j Φ
(
−µ
(tk)
i
σ
(tk)
i
)
1− Φ
(
−µ
(tk)
i
σ
(tk)
i
) ,
m
(tk)
i = E
(
Lij | Yobs,Θ(tk)
)
= µ
(tk)
i −
ψ
(
−µ
(tk)
i
σ
(tk)
i
)
Φ
(
−µ
(tk)
i
σ
(tk)
i
)σ(tk)i , (A.1)
M
(tk)
i = E
(
L2ij | Yobs,Θ(tk)
)
=
(
σ
(tk)
i
)2
+
(
µ
(tk)
i
)2
+
(
σ
(tk)
i
)2 ψ′(−µ(tk)iσ(tk)i
)
Φ
(
−µ
(tk)
i
σ
(tk)
i
) − 2µ(tk)i σ(tk)i ψ
(
−µ
(tk)
i
σ
(tk)
i
)
Φ
(
−µ
(tk)
i
σ
(tk)
i
) , (A.2)
and ψ(·) is the pdf of a standard normal distribution and ψ′ denote its first derivative. (A.1)
and (A.2) are the first and second moment of the truncated normal distribution. The tth
iteration of our nested EM algorithm takes the form:
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E1-step: Compute w(t)j = E
(
Dj|Cj,Θ(t)
)
as the E step in an ordinary EM algorithm.
E2-step:
Z
(t+ k−1K )
ij = E
(
Zij|Cij, w(t)j ,Θ(
t+ k−1
K )
)
= Pr
(
Zij = 1|Cij, w(t)j ,Θ(
t+ k−1
K )
)
=
f
(
Zij = 1, Cij, w
(t)
j |Θ(
t+ k−1
K )
)
f
(
Zij = 1, Cij, w
(t)
j |Θ(
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K )
)
+ f
(
Zij = 0, Cij, w
(t)
j |Θ(
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K )
)
=

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π
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π
(t+ k−1K )
j
)1−w(t)
j
+
(
1−π
(t+ k−1K )
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if Cij = 0;
0 if Cij 6= 0,
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M1-step: φ(t+1) =
∑J
j=1w
(t)
j /J .
M2-step:
π
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i=1 Z
(t+ k−1K )
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I
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2.
For k = 1, . . . , K, the tth iteration repeats E2-step and M2-step K times. Upon completion
of the K cycles, we set
(
π(t+1), δ(t+1),µ(t+1),σ(t+1)
)
=
(
π(t+
K
K
), δ(t+
K
K
),µ(t+
K
K
),σ(t+
K
K
)
)
.
68
A.3. Performance Evaluation via Simulation
A.3.1. Settings
Our mixture model assumes a common sample-specific effect for all expressed genes,
represented by the mean of the truncated normal distribution for a given sample. In re-
ality, the RNA degradation rates are not the same among genes in a given sample due
to a variety of factors. For example, Chen et al. [6] studied genome-wide mRNA degra-
dation and showed that RNA degradation is dependent on the distance relative to the
mRNA’s 5’ end. Environmental conditions also have effects on gene-wise degradation
rates. However, without using covariate information about such factors that may be hard
to obtain, none of the six normalization methods can separate the gene-wise degradation
effects from the true expression levels. To avoid overly optimistic results, we considered
the gene-wise degradation effects in our simulation by generating the gene-wise noise gj
from N(0, σ2g) with σg = 1.5 for all expressed genes. Specifically, the following data gener-
ating model was used: Cij ∼ ZIP(πj, δi) for j > φJ and Lij ∼ TN(µi + gj, σ2i , 0,+∞) for
j ≤ φJ , where φ indicates the proportion of expressed genes, and φJ is the number of
expressed genes rounded to the nearest integer. We then generated data under various
scenarios using the above model based on a real dataset for clear cell renal cell carci-
noma (ccRCC) in Eikrem et al. [13], which contains 18, 458 genes and 32 FFPE samples.
The proposed mixture model was fit on the ccRCC data and the MLEs of the parameters
were obtained. Then for each setting considered in the first five simulation studies de-
scribed below, we generated 100 data sets independently, all with I = 32 and J = 18, 458,
to examine the impact of one parameter at a time by varying its value from the MLE while
fixing other parameters at their respective MLEs.
The first simulation study is to evaluate the performance of the six methods by varying
the proportion of expressed genes. In settings I-1 to I-5, the data sets were generated
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with (π, δ,µ,σ) fixed, but φ = 0.59, 0.69, 0.79, 0.89 and 0.99, respectively. Note that the
MLE φ̂ = 0.79. Therefore, setting I-3 can be treated as the reference setting in which we
used the MLEs for all the parameters.
Study II is to examine the performance under different scenarios of the sample-specific
effects. In setting II-1, µis were increased to 2 times of their MLEs, reflecting the situation
where expressed genes have larger sample-specific effects. In setting II-2, to reflect
the situation where expressed genes have larger variability in their expression levels, we
increased σis by 2 times. In setting II-3, δis were increased to 2 times of their MLEs
to reflect the situation where non-expressed genes have larger sample-wise background
noise.
Study III is to examine the performance of the methods under different scenarios of
the gene-specific effects. In setting III-1, σg was increased from 1.5 to 3, reflecting larger
variability of the gene-wise noise gjs for expressed genes. In setting III-2, πjs were set
to a half of their MLEs, reflecting reduced probabilities of the perfect zero state for non-
expressed genes.
Study IV is to evaluate the robustness of MIXnorm when the model assumptions are
violated. In setting IV-1, with all the parameter values set to their MLEs and σg = 1.5, we
replaced TN(µi, σ2i , 0,+∞) by a generalized Student’s t-distribution truncated to [0,+∞),
namely t[0,+∞)(µti, σti , ν), for expressed genes. We set the number of degrees of freedom
ν to 3, creating the heaviest tails when the second moment of t[0,+∞)(µti, σti , ν) exists,
and set µti and σti to the values such that the mean and variance of t[0,+∞)(µti, σti , ν) were
equal to the mean and variance of TN(µi, σ2i , 0,+∞) [27]. In setting IV-2, we replaced
TN(µi, σ2i , 0,+∞) by Gamma(αi, βi) for expressed genes. We set αi = 2 so that the
gamma distribution has a positive skewness equal to
√
2/2 and βi was chosen so that the
mean of the gamma distribution was matched to that of TN(µi, σ2i , 0,+∞), and all other
parameters were kept the same as in setting IV-1. In setting IV-3, we used the PoissonSeq
model (i.e. model 3.1 from [31]) to generate data, with modification that intends to better
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mimic real FFPE samples. In their model 3.1, the raw count Cij ∼ Poisson(uij), and
log uij = log(di) + log(βj) + αi + γjyi, where di is the sequencing depth of sample i, βj
is the expression level of gene j, γj is the slope for the association of gene j with the
quantitative outcome yi, and αi is added to reflect different degradation levels for FFPE
samples. To account for excess zeros in FFPE data, (1 − φ) × 18, 458 genes were set to
be not expressed with βj = 1× 10−5, where φ is set to its MLE estimated from the ccRCC
data. All the other model parameters were generated based on the setting in Section 6 of
the Supplementary Material in [31].
Study V is to compare two normalization strategies when differentially expressed (DE)
genes exist between two experimental conditions: separate normalization for each con-
dition vs. pooled normalization for both conditions. Here, we randomly assigned the 32
samples into two equal sized groups. Then d% of the expressed genes were randomly
selected and set to be non-expressed genes in one group, whose read counts were gen-
erated from ZIP distributions. We set d to 5, 10 and 15 for settings V-1, V-2 and V-3. All
the other parameters were set to their MLEs as in setting I-3.
The last study VI is to examine the the computing time of MIXnorm when applied to
data sets with different sample sizes or numbers of genes. In setting VI-1, data were gen-
erated with parameters fixed at their MLEs, J = 18, 458, and σg = 1.5, but the sample size
I was set to a multiple of 32 (i.e., I = 32m for m = 1, 2, . . . , 48), where sample-specific pa-
rameters µi, σi and δi were duplicated m times correspondingly. The average computing
time for MIXnorm over 50 replicate data sets was recorded for each m. When the sample
size is large, monitoring convergence by the change of likelihood between consecutive
iterations becomes numerically unreliable. Thus, the maximum change among parameter
updates for all parameters were used to detect convergence in this simulation study. In
setting VI-2, the sample size was fixed at 32 but the number of genes was raised from
20, 000 to 50, 000 with 1, 000 increment. The proportion of expressed genes was set to the
MLE of φ.
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A.3.2. Results
For a specific sample i, the true expression in the log scale for any expressed gene j
was calculated by subtracting the gene-wise noise gj and the sample-specific effect (i.e.,
the mean of the TN distribution given by µi + ψ
(
−µi
σi
)
σi/Φ
(
−µi
σi
)
) from the generated
log expression Lij. The true expression for any non-expressed gene is zero across all
samples. The gene-wise Pearson correlations for the 18, 458 genes between the normal-
ized and true expression were calculated for each simulated data set and the combined
data set based on all the 100 replicates to evaluate the performance of the six methods
on normalization. Since MIXnorm works on the log transformed counts directly, for the
existing methods, we transformed the (normalized and true) expression levels into the log
scale before calculating the correlations to ensure a fair comparison. There exist cases
where the correlations are ill defined. For genes that have zero standard deviation (SD)
in both normalized and true expression, the correlations are simply set to 1 because they
are actually the genes with true and normalized expression both equal to zero across
all samples. For genes that have zero SD in true (normalized) expression, but not in
normalized (true) expression, we added a small amount of disturbance generated from
N(0, 1 × 10−4) to the true (normalized) expression when the corresponding normalized
(true) expression is not zero, in order to compute the correlations. Within each data set,
the first, second (i.e., median) and third quartiles of the 18, 458 gene-wise Pearson corre-
lations were recorded as summary statistics. In each simulation setting, box-plots were
used to summarize the three quartiles from the 100 replicates, and the box-plot of the
18, 458 gene-wise Pearson correlations calculated from the combined data, which con-
tains 100× 32 samples, were also generated.
Figure A.1 shows that when the proportion of expressed genes φ varies from 0.59
to 0.99, the third quartile appears to be more affected than the first two quartiles for
MIXnorm. In contrast, for the other five methods, the first quartile appears to be more
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affected than the last two quartiles. MIXnorm performs the best in settings I-1 to I-3 with
regard to all the three quartiles. In settings I-4 and I-5 with high proportions of expressed
genes 0.89 and 0.99, MIXnorm, PS and DEseq have comparable top performance, fol-
lowed by RPM and TMM, and last by UQ. The all-correlation plots in Figure A.1 confirm
that overall, MIXnorm has a large advantage over the other methods when φ is relatively
low, which is often true for FFPE samples due to the RNA degradation. This advantage
may come from the precise identification of expressed genes, which is a unique feature
of MIXnorm compared to the other normalization methods. Table A.1 reports the average
proportion of genes identified as expressed (i.e., genes with w(T )j > 0.5) by MIXnorm and
the average Area Under Curve (AUC) of receiver operating characteristic (ROC) curves
under each of the five settings. The proportions identified are very close to true propor-
tions and the AUCs are all close to 1, which clearly shows that MIXnorm is highly accurate
in identifying expressed genes.
The results from Study II are shown in Figure A.2, where the different sample-specific
effects µi, σi and δi are examined. The boxplots show that among the six methods,
MIXnorm gives the highest gene-wise correlations in all three settings. Further, the all-
correlation plots show that MIXnorm has the shortest whiskers on the left, meaning that
MIXnorm consistently produces fewer negative or low correlations. Among the existing
methods, PS and DEseq appear to perform the best, and can offer performance close or
comparable to MIXnorm in terms of the three quartiles.
Figure A.3 presents results from Study III, which investigates the impact of gene-wise
effects on the performance of the methods. In setting III-1 where the variability of gene-
wise noise σg was increased to 3 for expressed genes, the performance of all the six
methods becomes worse, compared to the reference setting I-3. However, MIXnorm still
shows advantage over the other methods with higher correlation quantiles. In setting
III-2 where πjs were set to a half of their MLEs to increase the gene-wise noise for non-
expressed genes, all the methods show lower correlation quartiles compared to those of
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setting I-3. But MIXnorm is less sensitive and yields much higher first quartiles and higher
other quartiles than the other methods.
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Figure A.1: Simulation study I: the first three columns show box-plots for the 1st to 3rd
quartiles of 18, 458 gene-wise correlations between normalized and true expression lev-
els based on 100 replicates for the five settings I1 - I5 that vary the proportion of expressed
genes φ from 0.59 to 0.99 by 0.1; the last column shows the box-plot of the 18, 458 gene-
wise Pearson correlations calculated from the combined data, which contains 100 × 32
samples in each setting. The MLE φ̂ estimated from the ccRCC data is 0.79, which is the
value of φ in Setting I-3 that can be treated as the reference setting.
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Setting Proportion of expressed genes Avg. proportion detected Avg. AUC
I-1 0.59 0.595 0.994
I-2 0.69 0.691 0.998
I-3 0.79 0.790 1.000
I-4 0.89 0.890 1.000
I-5 0.99 0.990 1.000
Table A.1: Simulation study I: the performance of MIXnorm in identifying expressed
genes, measured by the average proportion of genes detected as expressed (column
3) and the average AUC (column 4) in each of the five settings I1 – I5. Gene j is identified
as expressed if w(t)j > 0.5 in the last iteration.
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Figure A.2: Simulation study II: the first three columns show box-plots for the 1st to 3rd
quartiles of 18, 458 gene-wise correlations between normalized and true expression based
on 100 replicates for the three settings II1 – II3; the last column shows the box-plot of
the 18, 458 gene-wise Pearson correlations calculated from the combined data, which
contains 100×32 samples in each setting. In II-1, the sample specific location parameters
µis were increased to 2 times of their MLEs obtained from the ccRCC data. In II-2, the
sample specific scale parameters σis were increased to 2 times of their MLEs. In II-3,
δis, which control the sample specific background noise for non-expressed genes, were
increased to 2 times of their MLEs.
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Figure A.3: Simulation study III: the first three columns show box-plots for the 1st to 3rd
quartiles of 18, 458 gene-wise correlations between normalized and true expression levels
based on 100 replicates for the two settings III1 – III2; the last column shows the box-plot
of the 18, 458 gene-wise Pearson correlations calculated from the combined data, which
contains 100×32 samples in each setting. In setting III-1, the variability of gene-wise noise
σg was increased from 1.5 to 3 for expressed genes. In setting III-2, πjs, the probabilities
of extra zero for non-expressed genes, were set to a half of their MLEs.
Figure A.4 shows results from Study IV, in which deviations from model assumptions
were considered. In settings IV-1 and IV-2, where heavy-tailed and skewed data were
generated for expressed genes, respectively, we observe that MIXnorm, PS and DEseq
offer better performance than the other methods, among which MIXnorm is better than
or at least comparable to PS and DEseq. In setting IV-3, where the (modified) Poisson
log-linear model was used to generate data, all the methods produce wider box-plots,
indicating larger variability, and MIXnorm beats the other methods in all three quartiles.
Figure A.5 shows that when there exist DE genes, separate normalization yields better
performance. The difference between separate and pooled normalization is small when
d = 5, but it increases as d increases. Thus, we recommend using MIXnorm to normalize
data from different conditions separately, especially when the proportion of DE genes is
not small.
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Figure A.4: Simulation study IV: the first three columns show box-plots for the 1st to
3rd quartiles of 18, 458 gene-wise correlations between normalized and true expression
based on 100 replicates for the three settings IV1 - IV3; the last column shows the box-plot
of the 18, 458 gene-wise Pearson correlations calculated from the combined data, which
contains 100 × 32 samples in each setting. In IV-1, a truncated t-distribution was used to
generate heavy-tailed data for expressed genes.In IV-2, a gamma distribution was used to
generate skewed data for expressed genes. In IV-3, the Poisson log-linear model (model
3.1 from [31]), with modification to better mimic RNA-seq data from FFPE samples, was
used.
Figure A.6 shows the average computing time (in second) of MIXnorm against the
sample size I (the left panel) and against the number of genes J (the right panel) while
holding the other constant. Clearly, the average computing time increases linearly as I
or J increases, with Pearson correlation greater than 0.99, indicating a virtually perfect
linear relationship in each scatterplot. MIXnorm takes about 7 minutes for a data set with
∼ 1, 500 samples and ∼ 18, 000 genes.
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Figure A.5: Simulation study V: the first three columns show box-plots for the 1st to
3rd quartiles of 18,458 gene-wise correlations between normalized and true expression
based on 100 replicates for three settings V1 – V3; the last column shows the box-plot of
the 18, 458 gene-wise Pearson correlations calculated from the combined data, which con-
tains 100×32 samples in each setting. Two strategies are compared when DE genes exist
across two experimental conditions: separate normalization for each condition vs. pooled
normalization for both conditions. Each setting contains d% genes that are differentially
expressed, where d was set to 5, 10 and 15, respectively.
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Figure A.6: Simulation study VI: average computing time of MIXnorm vs. sample size I
(left panel) and number of genes J (right panel)
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A.4. Additional Results for Data Applications
To check the suitability of MIXnorm for the ccRCC data, Figure A.7 shows empirical
densities of log read counts for the 32 paired FFPE and RNAlater samples. As in Figure 1
for the soft tissue sarcomas data in the main paper, the density curves are all bimodal,
with one spike at zero, which necessitates the use of a zero-inflated distribution for non-
expressed genes. Also, the curves around the second mode are roughly bell-shaped,
suggesting that (truncated) normality is plausible for expressed genes. It is worth noting
that in this ccRCC example, the FFPE and FF density plots are quite similar, which implies
that the quality of FFPE data is almost identical to that of RNAlater data. Also, the location
of Lij may vary from sample to sample but the spread of Lij appears to be quite constant,
meaning that we need the sample-specific mean µi but could reduce the variance σ2i to a
constant σ2.
Figure A.7: An exploratory analysis of ccRCC RNA-seq data in Eikrem et al. (2016).
Panel (a) plots the empirical densities of log read counts for the 32 FFPE samples. Panel
(b) plots the empirical densities of log read counts for the paired RNAlater samples. Each
curve represents the density for one sample across all the 18, 458 protein coding genes.
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Figure A.8: Q-Q plots using the expressed genes identified by MIXnorm for four randomly
selected FFPE samples (NF10, NF31, TF32 and TF33) from ccRCC RNA-seq data. The
raw reads were transformed into the log scale to calculate sample quantiles. Theoreti-
cal quantiles were calculated from the TN distributions with sample-specific location and
scale parameters estimated by MIXnorm.
Besides the above explanatory analysis, we suggest conducting a confirmatory anal-
ysis after applying MIXnorm, by visually examining Q-Q plots or conducting distributional
tests, to check whether the assumption of (truncated) normality is adequate for expressed
genes in most of the samples. We first identified expressed genes by applying MIXnorm.
Among the 32 samples in the ccRCC data, we randomly selected 4 samples to show the
Q-Q plots in Figure A.8. The theoretical quantiles for the expressed genes were calcu-
lated using (µ̂i, σ̂2i ), the sample-specific TN parameters estimated from the nested EM al-
gorithm. We further conducted a distributional test for each sample, where the difference
between the distribution of log transformed reads for expressed genes and the theoreti-
cal probability distribution TN(µ̂i, σ̂2i , 0,+∞) was measured by the Kullback–Leibler (KL)
divergence. We employed bootstrap resampling to control the type I error rate at the sig-
81
nificance level 0.05. With 500 bootstrap samples, the p-value was empirically calculated
as the proportion of bootstrap KL divergence greater than the observed KL divergence.
We summarized the p-values from the bootstrap KL tests in Figure A.9. Both Q-Q plots
and p-values suggest that there was no gross departure from the assumed TN distribu-
tions.
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Figure A.9: Results from bootstrap KL distributional tests for the 32 FFPE samples from
ccRCC RNA-seq data. Note that the y-axis represents − log10(p-value). The horizontal
line is located at y = − log10(0.05). All p-values are greater than 0.05.
To investigate the impact of removing genes with low expression on normalization
performance, we adopted the quality control criterion from PoissonSeq [31]. Genes with
mean reads across all samples less than or equal to 0.5 were excluded for normalization
and correlation calculation. The preprocessed soft tissue sarcomas data contain 19, 408
genes and the ccRCC data contain 16, 044 genes. All the 67 genes in the CINSARC gene
signature passed the quality control. Table A.2 summarizes results based on gene-wise
correlations, where the left panel is for the CINSARC gene signature and the middle panel
is for the 19,408 genes in the soft tissue sarcomas data, and the right panel is for the
16, 044 genes in the ccRCC data. MIXnorm gives similar results regardless of conducting
quality control or not. DEseq and RPM normalization shows significant improvement on
the CINSARC gene signature, especially in terms of the median and 3rd quartile. Among
82
the six methods, MIXnorm is still the best, though it is overtaken by DEseq and RPM
for the 3rd Quartile in the CINSARC gene signature. Note that the selection of quality
control methods and thresholds can be subjective. MIXnorm achieves strong performance
without such an arbitrary preprocessing step.
Method
Soft tissue sarcomas ccRCC
CINSARC gene signature 19, 408 protein coding genes 16, 044 protein coding genes
1st. Qu. Median 3rd. Qu. 1st. Qu. Median 3rd. Qu. 1st. Qu. Median 3rd. Qu.
MIXnorm 0.333 0.456 0.517 0.094 0.226 0.367 0.284 0.483 0.680
DEseq 0.174 0.370 0.663 0.022 0.158 0.288 0.203 0.418 0.609
RPM 0.142 0.386 0.676 0.013 0.154 0.289 0.204 0.422 0.612
TMM 0.082 0.219 0.533 0.025 0.158 0.285 0.110 0.267 0.463
PS -0.126 0.002 0.154 -0.381 -0.161 0.022 0.107 0.299 0.484
UQ - - - - - - 0.236 0.425 0.606
Original 0.020 0.107 0.181 0.013 0.144 0.269 0.170 0.312 0.477
Table A.2: Data applications: the left and middle panels show gene-wise correlations
between normalized FFPE and FF expression for soft tissue sarcomas data; the right
panel shows gene-wise correlations between normalized FFPE and RNAlater expression
for ccRCC data. Genes with mean reads across all samples less than or equal to 0.5
were excluded for normalization and the correlation calculation. The filtered soft tissue
sarcomas data contain 19, 408 genes and ccRCC data contain 16, 044 genes.
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APPENDIX B
APPENDIX of CHAPTER 2
B.1. Nested EM algorithm for SMIXnorm
Consider the raw RNA-seq count data summarized in a matrix C, where the (i, j) ele-
ment Cij denotes the number of reads measured for sample i gene j and Lij = log(Cij+1)
for i = 1, ..., I and j = 1, .., J . Suppose we knew, through a binary latent variable Dj, if
gene j is truly expressed or not. Then we model the count data as a mixture of zero-
inflated Poisson (ZIP) and normal distribution,
Cij ∼ ZIP(πj, δ), if Dj = 0, (B.1)
Lij ∼ N (µi, σ2i ), if Dj = 1, (B.2)
Dj ∼ Ber(φ),
To obtain the maximum likelihood estimates (MLE), direct implementation of the EM
algorithm requires Newton-Raphson type optimization for parameters from the ZIP com-
ponent, which may suffer from both numerical stability and computational efficiency issues
[61, 67]. Note that ZIP distribution can be thought of as a mixture of the perfect zero state
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and the Poisson state. For each non-expressed gene j, we introduce another binary latent
variable Zij. Assume Cij is from the perfect zero state if Zij = 1 and Cij is from the Pois-
son state if Zij = 0. Obviously, Zij|Dj = 0 ∼ Ber(πj). The complete data log-likelihood
with latent variables D and Z is given by
`(Θ|C,D,Z) =
J∑
j=1
I∑
i=1
{
Dj [log φ+ log N(Lij|µi, σi)− log(Cij + 1)]
+ (1−Dj) [log (1− φ) + Zij log πj + (1− Zij) log (1− πj)]
+ (1−Dj) (1− Zij) [Cij log δ − δ − logCij! ]
}
, (B.3)
where Θ denote the set of all parameters. Let t be the current iteration of the nested EM
algorithm. Following van Dyk [61] and Yin et al. [67], the nested EM algorithm first treats
C as observed data andD as missing data in the outer EM and calculates the conditional
expectation w(t+1)j = E
(
Dj|Cj,Θ(t)
)
by
w
(t+1)
j =
φ(t)p(Cj|Dj = 1,µ(t),σ(t))
φ(t)p(Cj|Dj = 1,µ(t),σ(t)) + (1− φ(t))p(Cj|Dj = 0, π(t)j , δ(t))
, (B.4)
where p(Cj|Dj = 1,µ(t),σ(t)) is the normal probability density function and p(Cj|Dj =
0, π
(t)
j , δ
(t)) is the ZIP probability mass function as described in (B.1) and (B.2). The inner
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EM treats (C,w(t+1)) as observed data and Z as missing data and calculates Z(
t+ k−1
K )
ij by
Z
(t+ k−1K )
ij = E
(
Zij|Cij, w(t+1)j ,Θ(
t+ k−1
K )
)
= Pr
(
Zij = 1|Cij, w(t+1)j ,Θ(
t+ k−1
K )
)
=
p
(
Zij = 1, Cij, w
(t+1)
j |Θ(
t+ k−1
K )
)
p
(
Zij = 1, Cij, w
(t+1)
j |Θ(
t+ k−1
K )
)
+ p
(
Zij = 0, Cij, w
(t+1)
j |Θ(
t+ k−1
K )
)
=

(
π
(t+ k−1K )
j
)1−w(t+1)
j
(
π
(t+ k−1K )
j
)1−w(t+1)
j
+
(
1−π
(t+ k−1K )
j
)1−w(t+1)
j
exp
(
−δ
(t+ k−1K )
i
)1−w(t+1)
j
if Cij = 0;
0 if Cij 6= 0,
(B.5)
where k = 1, ..., K is the current cycle of the inner EM. The maximization step maximizes
the conditional expected complete data log-likelihood, which can be obtained by replacing
D and Z by w(t+1) and Z(t+
k−1
K ) in (B.3), with respect to Θ. The proposed nested EM
algorithm is summarized as follow:
Require: t = 0, convergence criteria ε, tolerance = ε+ 1, initialize (µ(0)i , σ
(0)
i , π
(0)
j , δ
(0), φ(0))
while tolerance > ε do
Calculate
w
(t+1)
j = E
(
Dj|Cj,Θ(t)
)
from (B.4)
for k in 1, 2, ..., K do
Calculate
Z
(t+ k−1K )
ij = E
(
Zij|Cij, w(t+1)j ,Θ(
t+ k−1
K )
)
from (B.5),
Update
π
(t+ kK )
j =
∑I
i=1 Z
(t+ k−1K )
ij
I
δ(t+
k
K ) =
∑J
j=1
(
1−w(t+1)j
)(
1−Z
(t+ k−1K )
ij
)
Cij
∑J
j=1
(
1−w(t+1)j
)(
1−Z
(t+ k−1K )
ij
)
end for
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Update
φ(t+1) =
∑J
j=1 w
(t+1)
j
J
µ
(t+1)
i =
∑J
j=1 w
(t+1)
j Lij∑J
j=1 w
(t+1)
j
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(t+1)
j
−
(
µ
(t+1)
i
)
2
Set
(
π(t+1), δ(t+1)
)
=
(
π(t+
K
K
), δ(t+
K
K
)
)
tolerance = |[`(Θ(t)|C)− `(Θ(t+1)|C)]/`(Θ(t)|C)|
t = t+ 1
end while
return MLE for all the parameters Θ̂
B.2. Web Appendix B: Additional simulation results
The following modified MIXnorm model [67] was used to generate synthetic data sets:
Cij ∼ ZIP(πj, δi), for j > φJ,
Lij ∼ TN (µi + gj, σ2i , 0,∞), for j ≤ φJ,
gj ∼ N(0, σ2g),
where gj is extra gene-wise noise and σg = 1.5. Other model parameters were set to their
MLEs estimated from a public RNA-seq dataset from FFPE soft tissue sarcomas samples
[30], which contains expression levels for 20, 242 protein-coding genes from 41 patients.
The performance of seven normalization methods is evaluated by the gene-wise Pear-
son correlations for the 20, 242 genes between the normalized and true expression. Fig. B.1
summarizes the correlation quantiles for the 50 simulated data sets under the setting of 41
87
samples. SMIXnorm and MIXnorm show almost identical correlation quartiles and have
significantly higher quartiles than others. TMM performs the best among the five existing
FF RNA-seq normalization methods. The most straightforward method, RPM, gives even
worse results than the use of original data without any normalization.
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Figure B.1: Simulation study I. The 1st to 3rd quartiles of gene-wise Pearson correlations
for 20, 242 genes between the normalized and true expression for 50 simulated data set
under the setting of 41 samples.
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APPENDIX C
APPENDIX of CHAPTER 3
C.1. MCMC algorithm
An efficient MCMC algorithm is designed to sample from the posterior distributions
of the model parameters and latent variables. As discussed in Section 3.2.3, we have
integrated out the Gaussian Process mean and variance scaling parameter to speed up
the MCMC convergence. In each MCMC iteration, we can directly sample G, and via a
data-augmentation method based on Polya-Gamma distributions, we can directly sample
β as well. Below we provide the M-H algorithms built in the Gibbs sampler to update λ
and Z.
Update of the underlying expression level Zi. From (3.3), Zi ≡ Yi with probability
1 given Gi = 1. We update Zi that corresponds to Gi = 0 sequentially by a Metropolis-
Hastings algorithm. We propose a new z∗i from Poi(zi) and then accept the proposed
value with probability min(1,mz), where the Hastings ratio is
mz =
p(z∗i |Gi = 0, λi, β0, β1)J(zi|z∗i )
p(zi|Gi = 0, λi, β0, β1)J(z∗i |zi)
,
where J(·|·) is the probability mass function of the proposal distribution. We set J(·|0) to
a Poisson distribution with mean 1 to avoid the algorithm from sticking at 0.
Update of the normalized expression level λi. We update each λi in natural loga-
rithm scale sequentially for i = 1, ..., I by a random walk Metropolis-Hastings algorithm.
We first propose a new log λ∗i from N(log λi, σ2λ). Then accept the proposed log λ
∗
i with
probability min(1,mz), where the Hastings ratio is
89
mλ =
p(log λ∗i |Z, l, logλ−i)J(log λi|log λ∗i )
p(log λi|Z, l, logλ−i)J(log λ∗i |log λi)
,
where the proposal density ratio J(log λi|log λ
∗
i )
J(log λ∗i |log λi)
= 1 in this random walk Metropolis-Hastings
algorithm.
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